scholarly article | Q13442814 |
P2093 | author name string | D Baltimore | |
R Sen | |||
P2860 | cites work | A gel electrophoresis method for quantifying the binding of proteins to specific DNA regions: application to components of the Escherichia coli lactose operon regulatory system | Q24594825 |
Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis | Q24633932 | ||
Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei | Q27860728 | ||
B lineage--specific interactions of an immunoglobulin enhancer with cellular factors in vivo | Q28306976 | ||
Cell-type-specific contacts to immunoglobulin enhancers in nuclei | Q28307043 | ||
Stimulation of in vitro transcription from the SV40 early promoter by the enhancer involves a specific trans-acting factor | Q33940287 | ||
BALB- and Harvey-murine sarcoma virus transformation of a novel lymphoid progenitor cell | Q36346891 | ||
A quantitative assay for transformation of bone marrow cells by Abelson murine leukemia virus | Q36359417 | ||
Fine Mapping of an Immunoglobulin Gene Activator | Q36945043 | ||
Expression and regulation of immunoglobulin heavy chain gene transfected into lymphoid cells. | Q41459613 | ||
Contribution of promoter to tissue-specific expression of the mouse immunoglobulin kappa gene | Q42814427 | ||
A transcription enhancer acts in vitro over distances of hundreds of base-pairs on both circular and linear templates but not on chromatin-reconstituted DNA | Q43676269 | ||
Immunoglobulin gene transcription is activated by downstream sequence elements | Q43904180 | ||
Immunoglobulin gene rearrangement in immature B cells | Q44289674 | ||
Cell-type specificity of immunoglobulin gene expression is regulated by at least three DNA sequence elements | Q45040167 | ||
Continuing kappa-gene rearrangement in a cell line transformed by Abelson murine leukemia virus | Q45799524 | ||
A trans-acting factor is responsible for the simian virus 40 enhancer activity in vitro | Q45839074 | ||
Preferential utilization of the most JH-proximal VH gene segments in pre-B-cell lines | Q48386738 | ||
A lymphocyte-specific enhancer in the mouse immunoglobulin kappa gene | Q48393280 | ||
A lymphocyte-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes | Q48397666 | ||
A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene | Q48397674 | ||
An RNA polymerase II transcription factor binds to an upstream element in the adenovirus major late promoter. | Q53785564 | ||
A protein binds to a satellite DNA repeat at three specific sites that would be brought into mutual proximity by DNA folding in the nucleosome. | Q53910276 | ||
Transcriptional Enhancer Elements in the Mouse Immunoglobulin Heavy Chain Locus | Q55062479 | ||
Regulation of the Escherichia coli l-arabinose operon studied by gel electrophoresis DNA binding assay | Q56659695 | ||
A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes | Q59066385 | ||
Correct transcription of an immunoglobulin κ gene requires an upstream fragment containing conserved sequence elements | Q59070373 | ||
Distinct factors bind to apparently homolgous sequences in the immunoglobulin heavy-chain enhancer | Q59097131 | ||
Immunoglobulin heavy-chain enhancer requires one or more tissue-specific factors | Q69936975 | ||
Transcription cell type specificity is conferred by an immunoglobulin VH gene promoter that includes a functional consensus sequence | Q69942457 | ||
An immunoglobulin promoter displays cell-type specificity independently of the enhancer | Q69947408 | ||
Specific interaction between enhancer-containing molecules and cellular components | Q70183912 | ||
Equilibrium studies of the cyclic AMP receptor protein-DNA interaction | Q70186335 | ||
Kinetics and mechanism in the reaction of gene regulatory proteins with DNA | Q70186340 | ||
Chromatin changes accompany immunoglobulin kappa gene activation: a potential control region within the gene | Q71621115 | ||
Ethylation interference and X-ray crystallography identify similar interactions between 434 repressor and operator | Q93598527 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | RELA proto-oncogene, NF-kB subunit | Q4047839 |
DNA-binding transcription factor activity, RNA polymerase II-specific | Q14864645 | ||
P304 | page(s) | 705-16 | |
P577 | publication date | 1986-08-29 | |
P1433 | published in | Cell | Q655814 |
P1476 | title | Multiple nuclear factors interact with the immunoglobulin enhancer sequences | |
P478 | volume | 46 |
Q33950784 | 26S proteasome inhibition induces apoptosis and limits growth of human pancreatic cancer |
Q39757580 | 3,4-Methylenedioxymethamphetamine alters left ventricular function and activates nuclear factor-Kappa B (NF-κB) in a time and dose dependent manner |
Q39086011 | 30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology |
Q38325962 | A 3'-flanking NF-kappaB site mediates developmental silencing of the human zeta-globin gene |
Q36720321 | A 36-kilodalton cellular transcription factor mediates an indirect interaction of human T-cell leukemia/lymphoma virus type I TAX1 with a responsive element in the viral long terminal repeat |
Q24633308 | A DNA-activated protein kinase from HeLa cell nuclei |
Q28189959 | A Rho exchange factor mediates fMet-Leu-Phe-induced NF-kappaB activation in human peripheral blood monocytes |
Q36666659 | A Striking Similarity in the Organization of the E-Selectin and Bate Interferon gene Promoters |
Q67728412 | A T cell nuclear factor resembling NF-AT binds to an NF-kappa B site and to the conserved lymphokine promoter sequence “cytokine-1” |
Q40761786 | A T cell-specific enhancer of the human CD40 ligand gene |
Q34301580 | A T-cell-specific transcriptional enhancer element 3' of C alpha in the human T-cell receptor alpha locus |
Q42154602 | A TEAD1/p65 complex regulates the eutherian-conserved MnSOD intronic enhancer, eRNA transcription and the innate immune response |
Q60072871 | A butterfly flutters by |
Q24634609 | A cDNA for a human cyclic AMP response element-binding protein which is distinct from CREB and expressed preferentially in brain |
Q73093466 | A caspase-3-like protease is involved in NF-kappaB activation induced by stimulation of N-methyl-D-aspartate receptors in rat striatum |
Q36784784 | A cell-specific enhancer of the mouse alpha 1-antitrypsin gene has multiple functional regions and corresponding protein-binding sites |
Q33930263 | A cellular transcription factor E4F1 interacts with an E1a-inducible enhancer and mediates constitutive enhancer function in vitro. |
Q36846475 | A common factor regulates skeletal and cardiac alpha-actin gene transcription in muscle |
Q34776433 | A compilation of composite regulatory elements affecting gene transcription in vertebrates |
Q33575084 | A conserved sequence in the T-cell receptor beta-chain promoter region |
Q36694624 | A dominant negative protein kinase C zeta subspecies blocks NF-kappa B activation |
Q40404716 | A factor stimulating transcription of the testis-specific Pgk-2 gene recognizes a sequence similar to the binding site for a transcription inhibitor of the somatic-type Pgk-1 gene |
Q33923274 | A family of constitutive C/EBP-like DNA binding proteins attenuate the IL-1 alpha induced, NF kappa B mediated trans-activation of the angiotensinogen gene acute-phase response element |
Q36753727 | A functional genomics screen for microRNA regulators of NF-kappaB signaling |
Q36796533 | A gamma interferon-unresponsive variant of cell line 70Z/3, IFN-4, can be partially rescued by phorbol myristate acetate |
Q36559257 | A glycine-rich region in NF-kappaB p105 functions as a processing signal for the generation of the p50 subunit |
Q72294674 | A gripping end to NF-kappa B |
Q24315939 | A helix-loop-helix protein related to the immunoglobulin E box-binding proteins |
Q36556749 | A homolog of human transcription factor NF-X1 encoded by the Drosophila shuttle craft gene is required in the embryonic central nervous system |
Q38347655 | A homologous in vitro system to analyze transcription of a mouse immunoglobulin mu heavy-chain gene |
Q35768654 | A labile repressor acts through the NFkB-like binding sites of the human urokinase gene |
Q24634606 | A large protein containing zinc finger domains binds to related sequence elements in the enhancers of the class I major histocompatibility complex and kappa immunoglobulin genes |
Q36758375 | A lipopolysaccharide-induced DNA-binding protein for a class II gene in B cells is distinct from NF-kappa B. |
Q40678565 | A lymphoid cell-specific nuclear factor containing c-Rel-like proteins preferentially interacts with interleukin-6 kappa B-related motifs whose activities are repressed in lymphoid cells |
Q40592420 | A mechanistic insight into a proteasome-independent constitutive inhibitor kappaBalpha (IkappaBalpha) degradation and nuclear factor kappaB (NF-kappaB) activation pathway in WEHI-231 B-cells |
Q47655100 | A molecular modeling study of inhibitors of nuclear factor kappa-B (p50)--DNA binding |
Q69807251 | A mouse renin promoter containing the conserved decanucleotide element binds the same B-cell factors as an authentic immunoglobulin heavy chain promoter |
Q28393278 | A multi-targeted approach to suppress tumor-promoting inflammation |
Q24299387 | A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins |
Q41070881 | A new approach to transfect NF-κB decoy oligodeoxynucleotides into the periodontal tissue using the ultrasound-microbubble method. |
Q89069089 | A noncanonical PPARγ/RXRα-binding sequence regulates leptin expression in response to changes in adipose tissue mass |
Q36705877 | A novel 7-nucleotide motif located in 3' untranslated sequences of the immediate-early gene set mediates platelet-derived growth factor induction of the JE gene |
Q37319289 | A novel RBP-J kappa-dependent switch from C/EBP beta to C/EBP zeta at the C/EBP binding site on the C-reactive protein promoter |
Q36558328 | A novel cis-acting element is essential for cytokine-mediated transcriptional induction of the serum amyloid A gene in nonhepatic cells |
Q24555708 | A novel complex between the p65 subunit of NF-kappa B and c-Rel binds to a DNA element involved in the phorbol ester induction of the human urokinase gene |
Q35248780 | A novel germ-line JK transcript starting immediately upstream of JK1 |
Q36711078 | A novel tumor necrosis factor-responsive transcription factor which recognizes a regulatory element in hemopoietic growth factor genes |
Q41644819 | A pre-B- and B cell-specific DNA-binding protein, EBB-1, which binds to the promoter of the VpreB1 gene. |
Q68294698 | A promoter of the rat insulin-like growth factor II gene consists of minimal control elements |
Q40391690 | A protein factor binding to an octamer motif in the gamma-globin promoter disappears upon induction of differentiation and hemoglobin synthesis in K562 cells |
Q42102630 | A rapid and high-throughput quantitation assay of the nuclear factor κB activity using fluorescence correlation spectroscopy in the setting of clinical laboratories |
Q38334402 | A serine/threonine kinase activity is closely associated with a 65-kDa phosphoprotein specifically recognized by the kappa B enhancer element |
Q34448815 | A short segment within the cytoplasmic domain of the neural cell adhesion molecule (N-CAM) is essential for N-CAM-induced NF-kappa B activity in astrocytes |
Q36353453 | A single pre-B cell can give rise to antigen-specific B cells that utilize distinct immunoglobulin gene rearrangements |
Q32052834 | A splice variant of E2-2 basic helix-loop-helix protein represses the brain-specific fibroblast growth factor 1 promoter through the binding to an imperfect E-box |
Q37412660 | A structural guide to proteins of the NF-kappaB signaling module |
Q48162656 | A survey of protein-DNA interaction sites within the murine immunoglobulin heavy chain locus reveals a particularly complex pattern around the DQ52 element |
Q42802906 | A three-protein-DNA complex on a B cell-specific domain of the immunoglobulin mu heavy chain gene enhancer |
Q36353891 | A tissue-specific transcriptional enhancer is found in the body of the HLA-DR alpha gene |
Q57378220 | A transcription factor which binds to the enhancers of SV40, immunoglobulin heavy chain and U2 snRNA genes |
Q40116375 | A unique enhancer element for the trans activator (p40tax) of human T-cell leukemia virus type I that is distinct from cyclic AMP- and 12-O-tetradecanoylphorbol-13-acetate-responsive elements. |
Q41974235 | A zinc-dependent DNA-binding activity co-operates with cAMP-responsive-element-binding protein to activate the human thyroglobulin enhancer |
Q92964973 | AEBP1 Promotes the Occurrence and Development of Abdominal Aortic Aneurysm by Modulating Inflammation via the NF-κB Pathway |
Q37376029 | Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer |
Q34570422 | Accessibility control of V(D)J recombination |
Q41756452 | Achieving transcriptional specificity with NF-kappa B. |
Q41545146 | Acquisition of NFKB1-selective DNA binding by substitution of four amino acid residues from NFKB1 into RelA. |
Q34190822 | Activation and attenuation of transcription factor NF-kB in mouse glomerular mesangial cells in response to tumor necrosis factor-alpha, immunoglobulin G, and adenosine 3':5'-cyclic monophosphate. Evidence for involvement of reactive oxygen species |
Q29618210 | Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B |
Q59073190 | Activation of HIV gene expression during monocyte differentiation by induction of NF-kB |
Q62907120 | Activation of NF-κB in the mouse spinal cord following sciatic nerve transection |
Q30439607 | Activation of Syk by protein kinase C-delta regulates thrombin-induced intercellular adhesion molecule-1 expression in endothelial cells via tyrosine phosphorylation of RelA/p65. |
Q39642244 | Activation of antiviral protein kinase leads to immunoglobulin E class switching in human B cells. |
Q33613910 | Activation of c-myc promoter P1 by immunoglobulin kappa gene enhancers in Burkitt lymphoma: functional characterization of the intron enhancer motifs kappaB, E box 1 and E box 2, and of the 3' enhancer motif PU. |
Q37557587 | Activation of endothelial-leukocyte adhesion molecule 1 (ELAM-1) gene transcription |
Q28646310 | Activation of interleukin-6 gene expression through the NF-kappa B transcription factor |
Q37290595 | Activation of kappa B-specific proteins by estradiol |
Q40785651 | Activation of nuclear factor-kappa b transcriptional activity in airway epithelial cells by thioredoxin but not by N-acetyl-cysteine and glutathione |
Q24812598 | Activation of nuclear factor-kappaB and not activator protein-1 in cellular response to nickel compounds. |
Q36325539 | Activation of nuclear factor-kappaB is necessary for myotrophin-induced cardiac hypertrophy |
Q38331909 | Activation of nuclear factor-kappaB-dependent transcription by tumor necrosis factor-alpha is mediated through phosphorylation of RelA/p65 on serine 529. |
Q35763936 | Activation of the NF-kappa B and I kappa B system in smooth muscle cells after rat arterial injury. Induction of vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1. |
Q36881679 | Activation of the human immunodeficiency virus long terminal repeat by herpes simplex virus type 1 is associated with induction of a nuclear factor that binds to the NF-kappa B/core enhancer sequence |
Q42455417 | Activation of the human immunodeficiency virus long terminal repeat by varicella-zoster virus IE4 protein requires nuclear factor-kappaB and involves both the amino-terminal and the carboxyl-terminal cysteine-rich region |
Q40787375 | Activation of the transcription factor NF-kappaB by the erythropoietin receptor: structural requirements and biological significance |
Q42443505 | Activation of transcription factor NF-kappa B by phagocytic stimuli in human neutrophils |
Q40103919 | Activation of transcription factors by extracellular nucleotides in immune and related cell types. |
Q29547882 | Activators and target genes of Rel/NF-kappaB transcription factors |
Q33918783 | Activity and interleukin 1 responsiveness of SV40 enhancer motifs in a rodent immature T cell line |
Q37724115 | Acute-phase reaction induces a specific complex between hepatic nuclear proteins and the interleukin 6 response element of the rat alpha 2-macroglobulin gene |
Q42084614 | Adipocyte enhancer-binding protein-1 promotes macrophage inflammatory responsiveness by up-regulating NF-kappaB via IkappaBalpha negative regulation |
Q39723868 | Adjacent proline residues in the inhibitory domain of the Oct-2 transcription factor play distinct functional roles. |
Q35661794 | Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications |
Q35923150 | Age-associated chronic diseases require age-old medicine: role of chronic inflammation |
Q34815793 | Ah receptor and NF-kappaB interactions: mechanisms and physiological implications |
Q41963865 | Alpha-melanocyte-related tripeptide, Lys-d-Pro-Val, ameliorates endotoxin-induced nuclear factor kappaB translocation and activation: evidence for involvement of an interleukin-1beta193-195 receptor antagonism in the alveolar epithelium |
Q36759388 | Alteration of a single nucleotide allows efficient binding of H2TF1/KBF1 to the immunoglobulin kappa enhancer B motif |
Q36826184 | Alterations in binding characteristics of the human immunodeficiency virus enhancer factor |
Q35263997 | Alternative nuclear functions for NF-κB family members |
Q38333075 | Alternative pathway for induction of human immunodeficiency virus gene expression: involvement of the general transcription machinery. |
Q43829203 | Amiloride blockades lipopolysaccharide-induced proinflammatory cytokine biosynthesis in an IkappaB-alpha/NF-kappaB-dependent mechanism. Evidence for the amplification of an antiinflammatory pathway in the alveolar epithelium |
Q40912739 | An efficient method for simultaneous isolation of biologically active transcription factors and DNA. |
Q41350016 | An enhancer element lies 3' to the human A gamma globin gene |
Q24651480 | An erythrocyte-specific DNA-binding factor recognizes a regulatory sequence common to all chicken globin genes |
Q35018471 | An improved SELEX-Seq strategy for characterizing DNA-binding specificity of transcription factor: NF-κB as an example |
Q41688788 | An in vitro transcription analysis of early responses of the human immunodeficiency virus type 1 long terminal repeat to different transcriptional activators |
Q36720562 | An inducible 50-kilodalton NF kappa B-like protein and a constitutive protein both bind the acute-phase response element of the angiotensinogen gene |
Q29618434 | An inducible transcription factor activates expression of human immunodeficiency virus in T cells |
Q36666995 | An interaction between the DNA-binding domains of RelA(p65) and Sp1 mediates human immunodeficiency virus gene activation |
Q59094880 | An octamer oligonucleotide upstream of a TATA motif is sufficient for lymphoid-specific promoter activity |
Q38984573 | An overview of the mechanisms and novel roles of Nrf2 in cardiovascular diseases |
Q38334997 | An region upstream of the gene promoter for the beta-amyloid precursor protein interacts with proteins from nuclear extracts of the human brain and PC12 cells |
Q37629085 | An updated meta-analysis of 37 case-control studies on the association between NFKB1 -94ins/del ATTG promoter polymorphism and cancer susceptibility |
Q38330046 | Analysis of proteins binding to the proximal promoter region of two rat serine protease inhibitor genes |
Q46255623 | Analysis of specificity for antigen, Mls, and allogenic MHC by transfer of T-cell receptor alpha- and beta-chain genes |
Q27679909 | Analysis of the RelA:CBP/p300 Interaction Reveals Its Involvement in NF-κB-Driven Transcription |
Q58707891 | Analysis of the negative transcriptional regulatory element in the angiotensin-converting enzyme gene |
Q34638187 | Analysis of the tissue-specific enhancer at the 3' end of the chicken adult beta-globin gene |
Q35708031 | Analysis of transcription factor remodeling in phase II gene expression with curcumin |
Q34482090 | Anaphylatoxins C5a and C3a induce nuclear factor kappaB activation in human peripheral blood monocytes |
Q33532900 | Angiotensinogen gene-inducible enhancer-binding protein 1, a member of a new family of large nuclear proteins that recognize nuclear factor kappa B-binding sites through a zinc finger motif |
Q34227176 | Anti-TNF-alpha therapies: the next generation |
Q38808870 | Anti-inflammatory Steroid from Phragmitis rhizoma Modulates LPS-Mediated Signaling Through Inhibition of NF-κB Pathway |
Q34830955 | Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors |
Q40760179 | Antioxidants inhibit cytokine production and suppress NF-kappaB activation in CAPAN-1 and CAPAN-2 cell lines |
Q35611859 | Antitumor effect of a novel nuclear factor-kappa B activation inhibitor in bladder cancer cells |
Q57116175 | Aphthous ulcer drug inhibits prostate tumor metastasis by targeting IKKɛ/TBK1/NF-κB signaling |
Q40229506 | Apo CIII gene transcription is regulated by a cytokine inducible NF-kappa B element |
Q34174773 | Apoptosis by Par-4 in cancer and neurodegenerative diseases |
Q41741254 | Apoptosis, neurotrophic factors and neurodegeneration |
Q58971701 | Are some controlling factors more equal than others? |
Q52844108 | Arginine Silicate Inositol Complex Accelerates Cutaneous Wound Healing. |
Q48714562 | Assembly and analysis of the mouse immunoglobulin kappa gene sequence |
Q24798022 | At the crossroads of SUMO and NF-kappaB |
Q44202845 | Atomic force microscopy identification of transcription factor NFkappaB bound to streptavidin-pin-holding DNA probe |
Q47915724 | Attenuation of DNA damage and mRNA gene expression in hypoxic rats using natural antioxidants |
Q34879939 | Autoregulation of I kappa B alpha activity |
Q36800459 | Avian reticuloendotheliosis virus-transformed lymphoid cells contain multiple pp59v-rel complexes |
Q38760990 | B and T cell antigen receptor repertoires in lupus/arthritis murine models |
Q34604518 | B lymphocyte-specific protein binding near an immunoglobulin kappa-chain gene J segment |
Q36846010 | B-cell control region at the 5' end of a major histocompatibility complex class II gene: sequences and factors |
Q36840366 | B-cell nuclear proteins binding in vitro to the human immunoglobulin kappa enhancer: localization by exonuclease protection |
Q35737918 | BAG-1 interacts with the p50-p50 homodimeric NF-κB complex: implications for colorectal carcinogenesis |
Q24315909 | BCL3 encodes a nuclear protein which can alter the subcellular location of NF-kappa B proteins |
Q97067010 | Baicalin, a Potent Inhibitor of NF-κB Signaling Pathway, Enhances Chemosensitivity of Breast Cancer Cells to Docetaxel and Inhibits Tumor Growth and Metastasis Both In Vitro and In Vivo |
Q28274858 | Beta-lapachone suppresses radiation-induced activation of nuclear factor-kappaB |
Q36133116 | Bicyclic Cyclohexenones as Inhibitors of NF-κB Signaling |
Q35004559 | Binding of NF-κB to nucleosomes: effect of translational positioning, nucleosome remodeling and linker histone H1. |
Q36833546 | Binding of a nuclear factor to a regulatory sequence in the promoter of the mouse H-2Kb class I major histocompatibility gene |
Q33556396 | Binding of host-cell factors to DNA sequences in the long terminal repeat of human T-cell leukemia virus type I: implications for viral gene expression |
Q36885717 | Binding of the herpes simplex virus immediate-early gene product ICP4 to its own transcription start site |
Q45841878 | Binding of tissue-specific factors to the enhancer sequence of hepatitis B virus |
Q34626976 | Binding of transcription factors and creation of a large nucleoprotein complex on the human cytomegalovirus enhancer |
Q35983857 | Blocking NF-κB: an inflammatory issue |
Q86691954 | Bortezomib: a therapeutic resource for the veterinary oncologist? |
Q41092928 | Both immunoglobulin promoter and enhancer sequences are targets for suppression in myeloma-fibroblast hybrid cells |
Q37361105 | Bradykinin stimulates NF-kappaB activation and interleukin 1beta gene expression in cultured human fibroblasts |
Q35627923 | C/EBP-related protein 2 confers lipopolysaccharide-inducible expression of interleukin 6 and monocyte chemoattractant protein 1 to a lymphoblastic cell line |
Q34042509 | CC2D1A, a DM14 and C2 domain protein, activates NF-kappaB through the canonical pathway |
Q71815069 | CD30 ligation induces nuclear factor‐ϰB activation in human T cell lines |
Q38646671 | CRISPR/Cas9-mediated knockout of c-REL in HeLa cells results in profound defects of the cell cycle. |
Q33960631 | Cachexia: a therapeutic approach beyond cytokine antagonism |
Q24301860 | Calcium-dependent regulation of tumour necrosis factor-alpha receptor signalling by copine |
Q36587800 | Cancer and diet: How are they related? |
Q89602953 | Cancer gene therapy by NF-κB-activated cancer cell-specific expression of CRISPR/Cas9 targeting telomeres |
Q36784281 | Capturing nuclear sequence-specific DNA-binding proteins by using simian virus 40-derived minichromosomes |
Q45253902 | Cardiac-specific blockade of NF-kappaB in cardiac pathophysiology: differences between acute and chronic stimuli in vivo |
Q40018293 | Casein kinase II phosphorylates I kappa B alpha at S-283, S-289, S-293, and T-291 and is required for its degradation |
Q38330193 | Cecropia immunoresponsive factor, an insect immunoresponsive factor with DNA-binding properties similar to nuclear-factor kappa B |
Q84576533 | Celebrating 25 years of NF-κB |
Q42144467 | Celebrating 25 years of NF-κB research |
Q61800023 | Cell Type-Specific Roles of NF-κB Linking Inflammation and Thrombosis |
Q36767046 | Cell cycle regulation of H2b histone octamer DNA-binding activity in Chinese hamster lung fibroblasts |
Q41107044 | Cell lineage specificity of chromatin configuration around the immunoglobulin heavy chain enhancer. |
Q64974714 | Cell of Origin and Genetic Alterations in the Pathogenesis of Multiple Myeloma. |
Q45944125 | Cell type- and developmental stage-specific activation of NF-kappaB by fMet-Leu-Phe in myeloid cells. |
Q41363076 | Cell type-specificity elements of the immunoglobulin heavy chain gene enhancer |
Q34974247 | Cell-bound IL-8 increases in bronchial epithelial cells after arylsulfatase B silencing due to sequestration with chondroitin-4-sulfate |
Q34370119 | Cell-cycle-specific interaction of nuclear DNA-binding proteins with a CCAAT sequence from the human thymidine kinase gene |
Q37122269 | Cell-permeable Tat-NBD peptide attenuates rat pancreatitis and acinus cell inflammation response |
Q34364296 | Cell-specific activity of the constituent elements of the simian virus 40 enhancer. |
Q87898936 | Cellular and behavioral effects of lipopolysaccharide treatment are dependent upon neurokinin-1 receptor activation |
Q37209676 | Cellular and biochemical studies of substituted guanine ribonucleoside immunostimulants |
Q73128997 | Cellular dissociation of NF-kappaB and inducible nitric oxide synthase in Helicobacter pylori infection |
Q42152859 | Cellular distribution of nuclear factor kappa B binding activity in rat liver |
Q40631511 | Cellular latency in HIV-1 infection. |
Q73347859 | Cellular redox status influences both cytotoxic and NF-kappa B activation in natural killer cells |
Q42616408 | Cellular transcripts encoded at a locus which permits retrovirus expression in mouse embryonic cells |
Q35937458 | Changes in NF-kappa B and ISGF3 DNA binding activities are responsible for differences in MHC and beta-IFN gene expression in Ad5- versus Ad12-transformed cells |
Q48917321 | Characterisation of tissue-specific trans-acting factor binding to a proximal element in the rat growth hormone gene promoter |
Q42832755 | Characteristics of the intron involvement in the mitogen-induced expression of Zfp-36. |
Q38351915 | Characterization of a CD43/leukosialin-mediated pathway for inducing apoptosis in human T-lymphoblastoid cells |
Q29618284 | Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity |
Q36830994 | Characterization of enhancer elements and their mutations in the long terminal repeat of feline endogenous RD-114 proviruses. |
Q40562257 | Characterization of human DNA sequences synthesized at the onset of S-phase |
Q40021606 | Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors |
Q45020308 | Characterization of nuclear protein binding to the interferon-gamma promoter in quiescent and activated human T cells. |
Q46021646 | Characterization of phycobiliprotein and linker polypeptide genes in Fremyella diplosiphon and their regulated expression during complementary chromatic adaptation. |
Q24607550 | Characterization of the Epstein-Barr virus-inducible gene encoding the human leukocyte adhesion and activation antigen BLAST-1 (CD48) |
Q28297573 | Characterization of the nonmuscle myosin heavy chain IIB promoter: regulation by E2F |
Q47634278 | Chelidonine inhibits TNF-α-induced inflammation by suppressing the NF-κB pathways in HCT116 cells. |
Q38297271 | Chemoattractant-stimulated NF-kappaB activation is dependent on the low molecular weight GTPase RhoA. |
Q34695119 | Chemosensitization of tumors by resveratrol |
Q43867588 | Chronic ethanol exposure potentiates lipopolysaccharide liver injury despite inhibiting Jun N-terminal kinase and caspase 3 activation |
Q37217744 | Cigarette smoke activates NF kappa B and induces Muc5b expression in mouse middle ear cells |
Q33937151 | Cigarette smoke activates NFκB-mediated Tnf-α release from mouse middle ear cells |
Q34514908 | Circuitry of nuclear factor kappaB signaling |
Q28279066 | Cis- and trans-acting elements involved in the regulation of the erythroid promoter of the human porphobilinogen deaminase gene |
Q24294398 | Cloning and characterization of a human c-myc promoter-binding protein |
Q24337872 | Cloning of GT box-binding proteins: a novel Sp1 multigene family regulating T-cell receptor gene expression |
Q46796894 | Cloning of HTLV-4 and its relation to simian and human immunodeficiency viruses |
Q24309237 | Cloning of an NF-kappa B subunit which stimulates HIV transcription in synergy with p65 |
Q24318577 | Cloning of the DNA-binding subunit of human nuclear factor kappa B: the level of its mRNA is strongly regulated by phorbol ester or tumor necrosis factor alpha |
Q34369151 | Cloning vectors for expression of cDNA libraries in mammalian cells |
Q39251309 | Combined effect of dehydroxymethylepoxyquinomicin and gemcitabine in a mouse model of liver metastasis of pancreatic cancer |
Q37427559 | Comparison of constitutive and inducible transcriptional enhancement mediated by kappa B-related sequences: modulation of activity in B cells by human T-cell leukemia virus type I tax gene |
Q56762921 | Comparison of two different DMA-binding modes of the NF-κB p50 homodimer |
Q33257781 | Comparison of two host cell range variants of feline immunodeficiency virus |
Q24599406 | Compilation of transcription regulating proteins |
Q36000787 | Complementation between two cell lines lacking kappa enhancer activity: implications for the developmental control of immunoglobulin transcription |
Q36924684 | Complex protein binding within the mouse immunoglobulin heavy-chain enhancer |
Q36711797 | Complex regulation of the immunoglobulin mu heavy-chain gene enhancer: microB, a new determinant of enhancer function |
Q38297326 | Concerted participation of NF-kappa B and C/EBP heteromer in lipopolysaccharide induction of serum amyloid A gene expression in liver |
Q38291608 | Conformational changes induced by DNA binding of NF-kappa B. |
Q42127127 | Conservation of transcriptional activation functions of the NF-kappa B p50 and p65 subunits in mammalian cells and Saccharomyces cerevisiae |
Q64102148 | Considering Abundance, Affinity, and Binding Site Availability in the NF-κB Target Selection Puzzle |
Q28582881 | Constitutive NF-kappa B activity in neurons |
Q38332164 | Constitutive activation of NF-kB in human thymocytes |
Q33719162 | Constitutive activation of nuclear factor-kappa B (NF-kB) signaling pathway in fibrolamellar hepatocellular carcinoma |
Q64921152 | Constitutive and NF-κB—like proteins in the regulation of the serum amyloid a gene by interleukin 1 |
Q41733125 | Constitutive and interleukin-1 (IL-1)-inducible factors interact with the IL-1-responsive element in the IL-6 gene |
Q38302429 | Constitutive nuclear NF-kappa B in cells of the monocyte lineage |
Q52446604 | Control of anthocyanin biosynthesis in flowers of Antirrhinum majus |
Q38230775 | Coordinate control of S phase onset and thymidine kinase expression |
Q42803437 | Coordinate inhibition of cytokine-mediated induction of ferritin H, manganese superoxide dismutase, and interleukin-6 by the adenovirus E1A oncogene |
Q34795531 | Correlation between nuclear factor κB activity and pulmonary artery pressure in a rat high pulmonary blood flow model |
Q40021091 | Costimulation by B7-1 and LFA-3 targets distinct nuclear factors that bind to the interleukin-2 promoter: B7-1 negatively regulates LFA-3-induced NF-AT DNA binding |
Q24316905 | Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation |
Q37333969 | Cowpox virus expresses a novel ankyrin repeat NF-kappaB inhibitor that controls inflammatory cell influx into virus-infected tissues and is critical for virus pathogenesis. |
Q35848528 | CpG methylation inhibits proenkephalin gene expression and binding of the transcription factor AP-2 |
Q55447785 | Critical molecular pathways in CLL therapy. |
Q26864198 | Critical role of NF-κB in pancreatic cancer |
Q67773785 | Cross-linking of surface IgM activates NF-xB in B lymphocyte |
Q28269382 | Cross-talk between transcription factors NF-kappa B and C/EBP in the transcriptional regulation of genes |
Q38199088 | Curcuma Contra Cancer? Curcumin and Hodgkin's Lymphoma |
Q38567932 | Current position of TNF-α in melanomagenesis |
Q40400073 | Cyclosporin A sensitivity of the NF-kappa B site of the IL2R alpha promoter in untransformed murine T cells |
Q41242119 | Cyclosporin A suppresses the expression of the interleukin 2 gene by inhibiting the binding of lymphocyte-specific factors to the IL-2 enhancer |
Q35533663 | Cytokine gene regulation: regulatory cis-elements and DNA binding factors involved in the interferon system |
Q40882342 | Cytokine production by CAPAN-1 and CAPAN-2 cell lines |
Q68236788 | Cytokine regulation of interleukin-6 gene expression in astrocytes involves activation of an NF-κ B-like nuclear protein |
Q40546176 | Cytokine-induced upregulation of NF-kappaB, IL-8, and ICAM-1 is dependent on colonic cell polarity: implication for PKCdelta |
Q34324777 | DNA and spermidine provide a switch mechanism to regulate the activity of restriction enzyme Nae I. |
Q67575970 | DNA binding of histone H1 is modulated by nucleotides |
Q35236157 | DNA curving and bending in protein-DNA recognition |
Q88337377 | DNA damage-induced nuclear factor-kappa B activation and its roles in cancer progression |
Q36787442 | DNA-binding factors of B lymphoid cells are susceptible to limited proteolytic cleavage during nuclear extract preparation |
Q36817732 | DNA-binding properties of the E1A-associated 300-kilodalton protein |
Q41754175 | DNase hypersensitivity and methylation of the human CD3G and D genes during T-cell development |
Q40958127 | Defects in signal transduction pathways in chronic B lymphocytic leukemia cells |
Q38359938 | Deletion of the Ig kappa light chain intronic enhancer/matrix attachment region impairs but does not abolish V kappa J kappa rearrangement |
Q77147370 | Demonstration of an activation regulated NF-kappaB/I-kappaBalpha complex in human platelets |
Q36780984 | Detection of two tissue-specific DNA-binding proteins with affinity for sites in the mouse beta-globin intervening sequence 2. |
Q40450686 | Determinant differences between the rabbit and mouse immunoglobulin kappa enhancers impair the activity of the rabbit enhancer in mouse myeloma cells. |
Q36168635 | Developing a Deeper Understanding of Autism: Connecting Knowledge through Literature Mining |
Q38695402 | Development and Characterisation of a Novel NF-κB Reporter Cell Line for Investigation of Neuroinflammation |
Q36806790 | Development of Novel 1,2,3,4-Tetrahydroquinoline Scaffolds as Potent NF-κB Inhibitors and Cytotoxic Agents |
Q39244165 | Developmental and tissue-specific expression of the Q5 k gene |
Q38342433 | Developmental regulation of specific protein interactions with an enhancerlike binding site far upstream from the avian very-low-density apolipoprotein II gene |
Q38329021 | Developmental regulation of the kappa locus involves both positive and negative sequence elements in the 3' enhancer that affect synergy with the intron enhancer |
Q30390478 | Dichotomous actions of NF-kappaB signaling pathways in heart |
Q28661903 | Diesel exhaust particles induce the over expression of tumor necrosis factor-alpha (TNF-alpha) gene in alveolar macrophages and failed to induce apoptosis through activation of nuclear factor-kappaB (NF-kappaB) |
Q40534584 | Different E-box regulatory sequences are functionally distinct when placed within the context of the troponin I enhancer |
Q40451275 | Differential activation of the 21-base-pair enhancer element of human T-cell leukemia virus type I by its own trans-activator and cyclic AMP. |
Q36650239 | Differential expression of Rel family members in human T-cell leukemia virus type I-infected cells: transcriptional activation of c-rel by Tax protein. |
Q36698580 | Differential human immunodeficiency virus expression in CD4+ cloned lymphocytes: from viral latency to replication |
Q36786744 | Differential protein binding in lymphocytes to a sequence in the enhancer of the mouse retrovirus SL3-3. |
Q28513046 | Differential regulation of the c-myc oncogene promoter by the NF-kappa B rel family of transcription factors |
Q36865840 | Differentiation and DNA contact points of host proteins binding at the cis site for virion-mediated induction of alpha genes of herpes simplex virus 1. |
Q39338015 | Dihydromyricetin suppresses TNF-α-induced NF-κB activation and target gene expression |
Q37135520 | Dihydrotestosterone stimulates cerebrovascular inflammation through NFkappaB, modulating contractile function |
Q34532234 | Dimethyl sulfoxide modulates NF-kappa B and cytokine activation in lipopolysaccharide-treated murine macrophages |
Q39821509 | Diphosphoryl lipid A from Rhodobacter sphaeroides transiently activates NF-kappa B but inhibits lipopolysaccharide induction of kappa light chain and Oct-2 in the B-cell lymphoma line 70Z/3. |
Q37003458 | Direct association of pp40/I kappa B beta with rel/NF-kappa B transcription factors: role of ankyrin repeats in the inhibition of DNA binding activity |
Q36000853 | Direct combinatorial interaction between a herpes simplex virus regulatory protein and a cellular octamer-binding factor mediates specific induction of virus immediate-early gene expression |
Q42552557 | Discovering NF-kappaB. |
Q41821982 | Disruption of the NF-κB/IκBα Autoinhibitory Loop Improves Cognitive Performance and Promotes Hyperexcitability of Hippocampal Neurons |
Q37144548 | Distinct Differentiation Programs Triggered by IL-6 and LPS in Teleost IgM(+) B Cells in The Absence of Germinal Centers. |
Q38315125 | Distinct NF-κB/Rel transcription factors are responsible for tissue-specific and inducible gene activation |
Q36845717 | Distinct combinations of NF-kappa B subunits determine the specificity of transcriptional activation |
Q41473567 | Distinct effects of glutathione disulphide on the nuclear transcription factor kappa B and the activator protein-1. |
Q40505363 | Distribution and characterization of helix-loop-helix enhancer-binding proteins from pancreatic beta cells and lymphocytes |
Q44963126 | Distribution of IkappaB proteins in gastric mucosa and other organs of mouse and gerbil |
Q36231310 | Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells |
Q37374611 | Divergent roles of RelA and c-Rel in establishing chromosomal loops upon activation of the Igkappa gene |
Q58796369 | Diverse molecular mechanisms of inhibition of NF-kappa B/DNA binding complexes by I kappa B proteins |
Q33562993 | Double-stranded RNA activates binding of NF-kappa B to an inducible element in the human beta-interferon promoter |
Q47146670 | Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer |
Q35845948 | Drosophila cellular immunity against parasitoids |
Q35147838 | Drosophila melanogaster antimicrobial defense |
Q40822288 | Dual control of C-reactive protein gene expression by interleukin-1 and interleukin-6. |
Q40566613 | Dual tissue-specific expression of apo-AII is directed by an upstream enhancer |
Q42812481 | ETS protein-dependent accessibility changes at the immunoglobulin mu heavy chain enhancer |
Q94528302 | Ectopic Expression of miR-532-3p Suppresses Bone Metastasis of Prostate Cancer Cells via Inactivating NF-κB Signaling |
Q47234828 | Effect of Dietary Acidolysis-Oxidized Konjac Glucomannan Supplementation on Serum Immune Parameters and Intestinal Immune-Related Gene Expression of Schizothorax prenanti |
Q40419711 | Effect of NF-kappaB constitutive activation on proliferation and apoptosis of gastric cancer cell lines |
Q38352184 | Effect of NF-κB inhibition on chemoresistance in biliary-pancreatic cancer. |
Q36409305 | Effect of NF-κB inhibitors on the chemotherapy-induced apoptosis of the colon cancer cell line HT-29. |
Q39414144 | Effect of antisense oligodeoxynucleotide targeted against NF-κB/P65 on cell proliferation and tumorigenesis of gastric cancer |
Q90087607 | Effect of morphine and a low dose of ketamine on the T cells of patients with refractory cancer pain in vitro |
Q47711817 | Effect of staurosporine on transcription factor NF-kappaB in human keratinocytes |
Q33262194 | Effects of IkappaBalpha and its mutants on NF-kappaB and p53 signaling pathways |
Q47276537 | Effects of Tianxiangdan Granule treatment on atherosclerosis via NF‑κB and p38 MAPK signaling pathways |
Q33769449 | Effects of a Proteasome Inhibitor on Cardiomyocytes in a Pressure-Overload Hypertrophy Rat Model: An Animal Study |
Q35867756 | Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication |
Q40887962 | Effects of anti-rheumatic gold salts on NF-kappa B mobilization and tumour necrosis factor-alpha (TNF-alpha)-induced neutrophil-dependent cytotoxicity for human endothelial cells |
Q28303823 | Effects of antioxidant enzyme modulations on interleukin-1-induced nuclear factor kappa B activation |
Q36830870 | Effects of long terminal repeat mutations on human immunodeficiency virus type 1 replication |
Q49379264 | Effects of nuclear factor‑κB on the uptake of 131iodine and apoptosis of thyroid carcinoma cells |
Q33580398 | Efficient DNA binding of NF-κB requires the chaperone-like function of NPM1. |
Q43152018 | Eggshell membrane hydrolyzates activate NF-κB in vitro: possible implications for in vivo efficacy |
Q38349910 | Electrophoretic assay for DNA-binding proteins |
Q41529161 | Elements in the immunoglobulin heavy-chain enhancer directly regulate simian virus 40 ori-dependent DNA replication |
Q72423701 | Elements of the maize A1 promoter required for transactivation by the anthocyanin B/C1 or phlobaphene P regulatory genes |
Q47807185 | Elevated serum concentrations of lipopolysaccharide binding protein might prolong sleep stage one in middle-aged hypertensive males |
Q28755808 | Elucidating the function of an ancient NF-kappaB p100 homologue, CrRelish, in antibacterial defense |
Q38530638 | Emerging roles of Lys63-linked polyubiquitylation in immune responses |
Q36652709 | Enhanced I kappa B alpha degradation is responsible for constitutive NF-kappa B activity in mature murine B-cell lines |
Q74420079 | Enhanced IkappaB kinase activity is responsible for the augmented activity of NF-kappaB in human head and neck carcinoma cells |
Q48862181 | Enhancement of immunoreactivity for NF-kappa B in human cerebral infarctions |
Q34373796 | Enhancer sequences of a retroviral vector determine expression of a gene in multipotent hematopoietic progenitors and committed erythroid cells |
Q36917130 | Enhancers and trans-acting E2 transcriptional factors of papillomaviruses |
Q48150331 | Enzymatic Self-Assembly Confers Exceptionally Strong Synergism with NF-κB Targeting for Selective Necroptosis of Cancer Cells |
Q24630870 | Epigenetic repression of the Igk locus by STAT5-mediated recruitment of the histone methyltransferase Ezh2 |
Q36380484 | Epstein-Barr virus binding to CD21 activates the initial viral promoter via NF-kappaB induction |
Q30452167 | Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity |
Q45742995 | Epstein-barr virus latent membrane protein (LMP1) induces specific NFkappaB complexes in human T-lymphoid cells |
Q37344828 | Establishment of stable reporter expression for in vivo imaging of nuclear factor-κB activation in mouse liver |
Q44219422 | Ethanol induces redox-sensitive cell-cycle inhibitors and inhibits liver regeneration after partial hepatectomy |
Q40796551 | Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions |
Q41690369 | Every enhancer works with every promoter for all the combinations tested: could new regulatory pathways evolve by enhancer shuffling? |
Q39768212 | Evidence Linking the Role of Placental Expressions of Peroxisome Proliferator-Activated Receptor-γ and Nuclear Factor-Kappa B in the Pathogenesis of Preeclampsia Associated With Periodontitis |
Q33676290 | Evidence for a trans-acting factor that regulates the transcription of class II major histocompatibility complex genes: genetic and functional analysis |
Q36743861 | Evidence that interleukin-1 and phorbol esters activate NF-kappa B by different pathways: role of protein kinase C. |
Q44470894 | Evolution of the rabbit immunoglobulin kappa chain genes. |
Q35687509 | Evolutionary consequences of nonrandom damage and repair of chromatin domains |
Q101475842 | Excess of the NF-ĸB p50 subunit generated by the ubiquitin ligase KPC1 suppresses tumors via PD-L1- and chemokines-mediated mechanisms |
Q21142672 | Expanding the substantial interactome of NEMO using protein microarrays |
Q54119837 | Experimental infections of Rana esculenta with Aeromonas hydrophila: a molecular mechanism for the control of the normal flora. |
Q57044361 | Exploring major signaling cascades in melanomagenesis: a rationale route for targetted skin cancer therapy |
Q34784913 | Expression and significance of HMGB1, TLR4 and NF-κB p65 in human epidermal tumors |
Q41976560 | Expression of HMGB1 and NF-κB p65 and its significance in non-small cell lung cancer |
Q33886675 | Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. |
Q46732847 | Expression of NF-kappaB in hRPE cells stimulated by PDTC and IL-1beta |
Q41136695 | Expression of a dominant negative I kappa B-alpha modulates hypersensitivity of ataxia telangiectasia fibroblasts to streptonigrin-induced apoptosis |
Q73226709 | Expression of cytokine genes and increased nuclear factor-kappa B activity in the brains of scrapie-infected mice |
Q38313274 | Expression of nuclear factor-kappaB in Helicobacter pylori-infected gastric mucosa detected with southwestern histochemistry |
Q36838691 | Expression of the c-myc oncogene under control of an immunoglobulin enhancer in E mu-myc transgenic mice |
Q34409631 | Expression of tumor necrosis factor alpha, TNF-related apoptosis-inducing ligand, and their associated molecules in ameloblastomas |
Q42272959 | Extensive cooperation of immune master regulators IRF3 and NFκB in RNA Pol II recruitment and pause release in human innate antiviral transcription |
Q41204949 | Extinction of Ig genes expression in myeloma x fibroblast somatic cell hybrids is accompanied by repression of the oct-2 gene encoding a B-cell specific transcription factor |
Q34421516 | FBI-1 enhances transcription of the nuclear factor-kappaB (NF-kappaB)-responsive E-selectin gene by nuclear localization of the p65 subunit of NF-kappaB. |
Q41789495 | Factor substitution in a human HSP70 gene promoter: TATA-dependent and TATA-independent interactions |
Q73479969 | Failure of lymphopoiesis after adoptive transfer of NF-kappaB-deficient fetal liver cells |
Q38299128 | Fatty liver vulnerability to endotoxin-induced damage despite NF-kappaB induction and inhibited caspase 3 activation |
Q42072936 | Fibroin gene promoter contains a cluster of homeodomain binding sites that interact with three silk gland factors |
Q36785036 | Fine-structure mapping of the three mouse alpha-fetoprotein gene enhancers |
Q33997517 | Footprint analysis of the RAG protein recombination signal sequence complex for V(D)J type recombination. |
Q33887799 | Forced expression of cyclin-dependent kinase 6 confers resistance of pro-B acute lymphocytic leukemia to Gleevec treatment |
Q35788803 | Frequent co-localization of Cox-2 and laminin-5 gamma2 chain at the invasive front of early-stage lung adenocarcinomas |
Q38138557 | Friend or foe: emerging role of nuclear factor kappa-light-chain-enhancer of activated B cells in cell senescence |
Q47873443 | From Classical Toxicology to Tox21: Some Critical Conceptual and Technological Advances in the Molecular Understanding of the Toxic Response Beginning From the Last Quarter of the 20th Century |
Q37837345 | From human autoantibodies to the fetal antibody repertoire to B cell malignancy: it's a small world after all. |
Q104495364 | From the T-cell receptor to cancer therapy: an interview with Tak W. Mak |
Q37570810 | Function of YY1 in Long-Distance DNA Interactions |
Q36362299 | Functional GATA-3 binding sites within murine CD8 alpha upstream regulatory sequences |
Q34865747 | Functional analysis and nucleotide sequence of the promoter region of the murine hck gene |
Q40421477 | Functional analysis of defined mutations in the immunoglobulin heavy-chain enhancer in transgenic mice |
Q36726934 | Functional analysis of the murine T-cell receptor beta enhancer and characteristics of its DNA-binding proteins |
Q38348120 | Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis |
Q40116360 | Functional characterization of a complex protein-DNA-binding domain located within the human immunodeficiency virus type 1 long terminal repeat leader region. |
Q36684975 | Functional characterization of the developmentally controlled immunoglobulin kappa 3' enhancer: regulation by Id, a repressor of helix-loop-helix transcription factors |
Q41173903 | Functional characterization of the transcription silencer element located within the human Pi class glutathione S-transferase promoter |
Q38292051 | Functional dissection of the brain-specific rat aldolase C gene promoter in transgenic mice. Essential role of two GC-rich boxes and an HNF3 binding site |
Q46413063 | Functional interaction of CARD15/NOD2 and Crohn's disease-associated TNFalpha polymorphisms |
Q28579505 | Functional interactions between an atypical NF-kappaB site from the rat CYP2B1 promoter and the transcriptional repressor RBP-Jkappa/CBF1. |
Q40506105 | Functional modularity in the SP6 kappa promoter |
Q40062844 | Functional similarities between human immunodeficiency virus type 1 and simian virus 40 kappa B proto-enhancers |
Q33805622 | Functions of protein phosphatase-6 in NF-κB signaling and in lymphocytes |
Q35184458 | Gamma herpesviruses: pathogenesis of infection and cell signaling |
Q41711827 | Gene expression, biological effects and clinical aspects of lymphokines |
Q58741389 | Gene transcription through activation of G-protein-coupled chemoattractant receptors |
Q36788374 | Genes activated in the presence of an immunoglobulin enhancer or promoter are negatively regulated by a T-lymphoma cell line |
Q24311010 | Genetic aspects of inflammation and cancer |
Q37612140 | Genetic polymorphism of NFKB1 and NFKBIA genes and liver cancer risk: a nested case-control study in Shanghai, China |
Q36071390 | Genetic variants associated with autoimmunity drive NFκB signaling and responses to inflammatory stimuli |
Q90006561 | Genome reading by the NF-κB transcription factors |
Q33688737 | Genome rearrangements activate the Epstein-Barr virus gene whose product disrupts latency |
Q36710023 | Genomic footprinting: detection of putative regulatory proteins in the promoter region of the interferon alpha-1 gene in normal human tissues |
Q37330635 | Genomic organization and evolution of immunoglobulin kappa gene enhancers and kappa deleting element in mammals |
Q35320928 | Glutathione and immunophenotypes of T and B lymphocytes in HIV-infected individuals |
Q46533992 | Glutathione depletion down-regulates tumor necrosis factor alpha-induced NF-kappaB activity via IkappaB kinase-dependent and -independent mechanisms |
Q35664175 | Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress |
Q34966171 | Growing old with nuclear factor-kappaB |
Q40396385 | HMGI(Y) and Sp1 in addition to NF-kappa B regulate transcription of the MGSA/GRO alpha gene |
Q55242466 | HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-kappa B-like factor. |
Q38295189 | Hammerhead ribozyme against gamma-glutamylcysteine synthetase sensitizes human colonic cancer cells to cisplatin by down-regulating both the glutathione synthesis and the expression of multidrug resistance proteins |
Q41010028 | Heat shock protein 70 overexpression affects the response to ultraviolet light in murine fibroblasts. Evidence for increased cell viability and suppression of cytokine release |
Q34803115 | Heat shock protein 90-mediated inactivation of nuclear factor-κB switches autophagy to apoptosis through becn1 transcriptional inhibition in selenite-induced NB4 cells |
Q36774107 | Helix-loo-helix proteins in the regulation of immunoglobulin gene transcription |
Q34288246 | Hepatitis B virus X gene activates kappa B-like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1. |
Q41639214 | Herbimycin A blocks IL-1-induced NF-kappa B DNA-binding activity in lymphoid cell lines |
Q38347799 | Herpes simplex virus regulatory elements and the immunoglobulin octamer domain bind a common factor and are both targets for virion transactivation |
Q36698102 | Herpes simplex virus type 1-mediated induction of human immunodeficiency virus type 1 provirus correlates with binding of nuclear proteins to the NF-kappa B enhancer and leader sequence |
Q36438405 | High concentration of L-arginine suppresses nitric oxide synthase activity and produces reactive oxygen species in NB9 human neuroblastoma cells |
Q41045694 | High constitutive NF-kappaB activity mediates resistance to oxidative stress in neuronal cells. |
Q40406472 | High level activity of the mouse CCAAT/enhancer binding protein (C/EBP alpha) gene promoter involves autoregulation and several ubiquitous transcription factors |
Q37411738 | High-throughput living cell-based optical biosensor for detection of bacterial lipopolysaccharide (LPS) using a red fluorescent protein reporter system |
Q33808140 | Hormonal regulation of the NF-kappaB signaling pathway |
Q35011002 | Human Calcitonin gene regulation by helix-loop-nelix recognition sequences |
Q72519758 | Human HE2 (microB) and microA motifs show the same function as whole IgH intronic enhancer in transgenic mice |
Q41431590 | Human T-cell leukemia virus type I Tax activation of NF-kappa B/Rel involves phosphorylation and degradation of I kappa B alpha and RelA (p65)-mediated induction of the c-rel gene |
Q36828828 | Human T-cell leukemia virus type I Tax induces expression of the Rel-related family of kappa B enhancer-binding proteins: evidence for a pretranslational component of regulation |
Q73764580 | Human alpha-galactosidase A: high plasma activity expressed by the -30G-->A allele |
Q28296828 | Human cellular retinol-binding protein gene organization and chromosomal location |
Q36781988 | Human cytomegalovirus ie1 transactivates the alpha promoter-enhancer via an 18-base-pair repeat element. |
Q35845633 | Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters |
Q35862161 | Human immunodeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of infection display a wide range of sequence polymorphism and transcription activity. |
Q38319909 | Human neuroblastoma cells produce the NF-kappa B-like HIV-1 transcription activator during differentiation |
Q36230139 | Human tumor necrosis factor alpha gene regulation in phorbol ester stimulated T and B cell lines |
Q40630149 | Hyperthermia enhances cytomegalovirus regulation of HIV-1 and TNF-alpha gene expression |
Q43977582 | Hypoosmotic stress stimulates growth in HepG2 cells via protein kinase B-dependent activation of activator protein-1. |
Q54858561 | Hypoxia and Inflammation in Cancer, Focus on HIF and NF-κB. |
Q34995070 | Hypoxia signaling to genes: significance in Alzheimer's disease |
Q55657572 | Hypoxia, Metabolism and Immune Cell Function. |
Q40335593 | Hypoxic induction of interleukin-8 gene expression in human endothelial cells |
Q24307786 | I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding |
Q38352037 | I(kappa)B(gamma) inhibits DNA binding of NF-kappaB p50 homodimers by interacting with residues that contact DNA. |
Q38142280 | I-E transgenic mice: a model system to dissect the regulation and function of MHC class II genes in vivo |
Q34973300 | IGH minisatellite suppression of USF-binding-site- and E mu-mediated transcriptional activation of the adenovirus major late promoter |
Q41070438 | IKK kinase assay for assessment of canonical NF-κB activation in neurons |
Q99412585 | Icariin-induced inhibition of SIRT6/NF-κB triggers redox mediated apoptosis and enhances anti-tumor immunity in TNBC |
Q36792784 | Identification and characterization of multiple erythroid cell proteins that interact with the promoter of the murine alpha-globin gene |
Q35619169 | Identification and characterization of two functional domains within the murine heavy-chain enhancer |
Q41177051 | Identification and functional characterization of a highly conserved sequence in the intron of the kappa light chain gene |
Q36007762 | Identification and partial purification of a protein binding to the human immunoglobulin kappa enhancer kappa E2 site |
Q33584734 | Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-kappa B) that activates transcription from a human immunodeficiency virus type 1 promoter in vitro |
Q24318843 | Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions |
Q38326073 | Identification of Ets-like lymphoid specific elements within the immunoglobulin heavy chain 3' enhancer |
Q35012208 | Identification of USF as the ubiquitous murine factor that binds to and stimulates transcription from the immunoglobulin λ2 chain promoter |
Q43182169 | Identification of a C/EBP-Rel complex in avian lymphoid cells |
Q34351818 | Identification of a DNA binding protein that recognizes the nonamer recombinational signal sequence of immunoglobulin genes. |
Q41331105 | Identification of a DNA sequence element required for efficient expression of a developmentally regulated and cAMP-inducible gene of Dictyostelium discoideum. |
Q34337193 | Identification of a cell-specific transcriptional enhancer in the first intron of the mouse alpha 2 (type I) collagen gene |
Q38332521 | Identification of a conserved lipopolysaccharide-plus-interleukin-4-responsive element located at the promoter of germ line epsilon transcripts |
Q36356965 | Identification of a functional NF-kappa B binding site in the murine T cell receptor beta 2 locus |
Q36757653 | Identification of a myocyte nuclear factor that binds to the muscle-specific enhancer of the mouse muscle creatine kinase gene |
Q90094609 | Identification of a novel 1,2 oxazine that can induce apoptosis by targeting NF-κB in hepatocellular carcinoma cells |
Q36564422 | Identification of a novel NF-kappaB p50-related protein in B lymphocytes |
Q36708461 | Identification of a novel factor that interacts with an immunoglobulin heavy-chain promoter and stimulates transcription in conjunction with the lymphoid cell-specific factor OTF2. |
Q36000827 | Identification of a novel lymphoid specific octamer binding protein (OTF-2B) by proteolytic clipping bandshift assay (PCBA). |
Q48132779 | Identification of a nuclear protein that constitutively recognizes the sequence containing a heat-shock element. Its binding properties and possible function modulating heat-shock induction of the rat heme oxygenase gene |
Q36755529 | Identification of a pancreatic beta-cell insulin gene transcription factor that binds to and appears to activate cell-type-specific expression: its possible relationship to other cellular factors that bind to a common insulin gene sequence |
Q36823461 | Identification of a rel-related protein in the nucleus during the S phase of the cell cycle |
Q35829923 | Identification of a second inducible DNA-protein interaction in the kappa immunoglobulin enhancer |
Q45946482 | Identification of a wound-induced inhibitor of a nuclear factor that binds the carrot extensin gene. |
Q40645885 | Identification of a yeast protein with properties similar to those of the immunoglobulin heavy-chain enhancer-binding protein NF-muE3. |
Q36717517 | Identification of an octamer-binding site in the human kappa light-chain enhancer |
Q36761913 | Identification of an octamer-binding site in the mouse kappa light-chain immunoglobulin enhancer |
Q68144945 | Identification of cellular differentiation-dependent nuclear factors that bind to a human gene for thymidylate synthase |
Q34311433 | Identification of cellular proteins that bind to the human immunodeficiency virus type 1 trans-activation-responsive TAR element RNA |
Q40647927 | Identification of cis-acting sequences responsible for phorbol ester induction of human serum amyloid A gene expression via a nuclear factor kappaB-like transcription factor |
Q42614068 | Identification of conserved and variable regions in the envelope glycoprotein sequences of two feline immunodeficiency viruses isolated in Zurich, Switzerland |
Q35497838 | Identification of haplotype tag single nucleotide polymorphisms within the nuclear factor-κB family genes and their clinical relevance in patients with major trauma |
Q36828649 | Identification of immediate-early-type cis-response elements in the promoter for the ribonucleotide reductase large subunit from herpes simplex virus type 2. |
Q33575182 | Identification of murine nuclear proteins that bind to the conserved octamer sequence of the immunoglobulin promoter region |
Q42506716 | Identification of novel NF-κB transcriptional targets in TNFα-treated HeLa and HepG2 cells |
Q36829325 | Identification of nuclear proteins that specifically interact with adeno-associated virus type 2 inverted terminal repeat hairpin DNA. |
Q36850004 | Identification of protein-binding sites in the hepatitis B virus enhancer and core promoter domains |
Q35194262 | Identification of the transcriptional unit, structural organization, and promoter sequence of the human sex-determining region Y (SRY) gene, using a reverse genetic approach |
Q35841357 | Identification of tissue specific nuclear proteins: DNA sequence and protein binding regions in the T cell receptor beta J-C intron |
Q36792077 | Identification of upstream and intragenic regulatory elements that confer cell-type-restricted and differentiation-specific expression on the muscle creatine kinase gene |
Q24306317 | Identification, cloning, and functional characterization of a murine lipoxin A4 receptor homologue gene |
Q39098951 | Identifying post-translational modifications of NEMO by tandem mass spectrometry after high affinity purification |
Q36039922 | IkappaB kinase: beginning, not the end |
Q45850803 | Immediate early protein of pseudorabies virus is a general transactivator but stimulates only suboptimally utilized promoters. A clue to specificity? |
Q35907925 | Immune factor Gambif1, a new rel family member from the human malaria vector, Anopheles gambiae |
Q92239132 | Immunity-related genes and signaling pathways under hypoxic stresses in Haliotis diversicolor: a transcriptome analysis |
Q34306285 | Immunoglobulin enhancer and promoter motifs 5' of the B29 B-cell-specific gene |
Q42262039 | Immunohistochemical and Stereologic Analysis of NF-κB Activation in Chronic Periodontitis |
Q24625466 | Impaired B cell development and function in the absence of IkappaBNS |
Q73224971 | Implications for tooth eruption of the effect of interleukin-1alpha on nuclear factor-kappaB gene expression in the rat dental follicle |
Q38814358 | Importance of the alternative NF-κB activation pathway in inflammation-associated gastrointestinal carcinogenesis. |
Q36399353 | Important roles for E protein binding sites within the immunoglobulin kappa chain intronic enhancer in activating Vkappa Jkappa rearrangement |
Q40659390 | In vitro transcription of immunoglobulin genes in a B-cell extract: effects of enhancer and promoter sequences |
Q35198112 | In vitro γ-ray-induced inflammatory response is dominated by culturing conditions rather than radiation exposures |
Q34450267 | In vivo circadian oscillation of dCREB2 and NF-κB activity in the Drosophila nervous system |
Q34069959 | In vivo control of NF-kappa B activation by I kappa B alpha. |
Q46982839 | In vivo effects of an inhibitor of nuclear factor-kappa B on thrombogenic properties of antiphospholipid antibodies |
Q38332154 | In vivo footprinting of rat TAT gene: Dynamic interplay between the glucocorticoid receptor and a liver-specific factor |
Q40545357 | In vivo functional analysis of in vitro protein binding sites in the immunoglobulin heavy chain enhancer |
Q41130580 | In vivo occupancy of the kappa light chain enhancers in primary pro- and pre-B cells: a model for kappa locus activation |
Q38335036 | In vivo stimulation of H-2Dd expression following RadLV infection of thymocytes: increased transcription and DNA-binding activity to sequences 5' of the Dd gene |
Q40565497 | Increased expression of NF-kappa B subunits in human pancreatic cancer cells |
Q35943557 | Inducible DNA-protein interactions of the murine kappa immunoglobulin enhancer in intact cells: comparison with in vitro interactions |
Q36619591 | Inducible and cell type-specific expression of VL30 U3 subgroups correlate with their enhancer design. |
Q40016147 | Inducible degradation of I kappa B alpha in vitro and in vivo requires the acidic C-terminal domain of the protein |
Q73046476 | Induction of B cell proliferation and NF-kappa B activation by a water soluble glycan from Lentinus lepideus |
Q36735443 | Induction of NF-kappa B DNA-binding activity during the G0-to-G1 transition in mouse fibroblasts |
Q40241454 | Induction of NF-kappa B-like activity by platelet-derived growth factor in mouse fibroblasts |
Q48380205 | Induction of NF-kappaB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells: suppression of NF-kappaB and neuroprotection by antioxidants. |
Q36404030 | Induction of early B cell factor (EBF) and multiple B lineage genes by the basic helix-loop-helix transcription factor E12. |
Q40396563 | Induction of heat shock protein 70 inhibits NF-kappa-B in squamous cell carcinoma |
Q40115517 | Induction of human interferon gene expression is associated with a nuclear factor that interacts with the NF-kappa B site of the human immunodeficiency virus enhancer |
Q39512381 | Infection of endothelial cells with Trypanosoma cruzi activates NF-kappaB and induces vascular adhesion molecule expression. |
Q40650845 | Infection with the intracellular protozoan parasite Theileria parva induces constitutively high levels of NF-kappa B in bovine T lymphocytes |
Q30452207 | Influence of enhancer sequences on thymotropism and leukemogenicity of mink cell focus-forming viruses. |
Q38843011 | Ingenane-type diterpene compounds from Euphorbia kansui modulate IFN-γ production through NF-κB activation |
Q36981852 | Inhibition of IκB kinase reduces the multiple organ dysfunction caused by sepsis in the mouse |
Q41084487 | Inhibition of NF-kappa B activity induces apoptosis in murine hepatocytes. |
Q30306196 | Inhibition of NF-kappaB sensitizes non-small cell lung cancer cells to chemotherapy-induced apoptosis |
Q41077008 | Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells |
Q38292699 | Inhibition of NF-κB specific transcriptional activation by PNA strand invasion |
Q40799697 | Inhibition of anchorage-independent growth and lung metastasis of A549 lung carcinoma cells by IkappaBbeta |
Q44217206 | Inhibition of glutathione-related enzymes augments LPS-mediated cytokine biosynthesis: involvement of an IkappaB/NF-kappaB-sensitive pathway in the alveolar epithelium |
Q39599067 | Inhibition of nuclear factor-kappaB suppresses peritoneal dissemination of gastric cancer by blocking cancer cell adhesion |
Q41808247 | Inhibition of protein kinase C zeta subspecies blocks the activation of an NF-kappa B-like activity in Xenopus laevis oocytes. |
Q36573962 | Inhibition of tumor growth by NF-kappaB inhibitors |
Q37907354 | Inhibitory kappa B Kinases as targets for pharmacological regulation |
Q34171696 | Injection of the cAMP-responsive element into the nucleus of Aplysia sensory neurons blocks long-term facilitation |
Q26773162 | Innate Immune Response in Brain, NF-Kappa B Signaling and Cystatins |
Q38320335 | Insect immunity. Two 17 bp repeats nesting a kappa B-related sequence confer inducibility to the diptericin gene and bind a polypeptide in bacteria-challenged Drosophila |
Q36679345 | Interaction between NF-kappa B- and serum response factor-binding elements activates an interleukin-2 receptor alpha-chain enhancer specifically in T lymphocytes |
Q36733128 | Interaction of a nuclear protein with a palindromic sequence of the mouse immunoglobulin lambda 2-chain gene promoter is important for its transcription |
Q33641587 | Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoter |
Q38341650 | Interaction of enhancer-binding protein EBP1 (NF-kappa B) with the human immunodeficiency virus type 1 enhancer. |
Q36776380 | Interaction of nuclear proteins with a positive cis-acting element of rat embryonic myosin heavy-chain promoter: identification of a new transcriptional factor |
Q37416496 | Interaction of the v-rel protein with an NF-kappa B DNA binding site |
Q45965084 | Interactions between NFkappaB and its inhibitor ikappaB: biophysical characterization of a NFkappaB/ikappaB-alpha complex. |
Q36832296 | Interactions between nuclear factors and the hepatitis B virus enhancer |
Q38348287 | Interactions of cellular proteins involved in the transcriptional regulation of the human immunodeficiency virus |
Q37527174 | Interactome maps of mouse gene regulatory domains reveal basic principles of transcriptional regulation. |
Q36767392 | Interleukin 1 and cyclic AMP induce kappa immunoglobulin light-chain expression via activation of an NF-kappa B-like DNA-binding protein |
Q28572615 | Interleukin 6 mediated differentiation and rescue of cell redox in PC12 cells exposed to ionizing radiation |
Q41529538 | Interleukin-1 activates transcription factor NF kappa B in glial cells |
Q38338064 | Interleukin-1-mediated enhancement of mouse factor B gene expression via NF kappa B-like hepatoma nuclear factor |
Q33686149 | Intracellular oxidation/reduction status in the regulation of transcription factors NF-kappaB and AP-1. |
Q37636106 | Investigation of NF-κB1 and NF-κBIA gene polymorphism in non-small cell lung cancer |
Q41121963 | Involvement of Stat3 in interleukin-6-induced IgM production in a human B-cell line |
Q28646316 | Involvement of a NF-kappa B-like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokines |
Q36711826 | Involvement of a second lymphoid-specific enhancer element in the regulation of immunoglobulin heavy-chain gene expression. |
Q38342040 | Involvement of different transduction pathways in NF-kappa B activation by several inducers |
Q40806948 | Involvement of intracellular Ca2+ in the regulation of bovine leukemia virus expression |
Q41147740 | Involvement of nuclear factor-kappa B activation in IgE synthesis in human B cells |
Q44258834 | Involvement of protein tyrosine kinase in Toll-like receptor 4-mediated NF-kappa B activation in human peripheral blood monocytes |
Q73109709 | Involvement of reactive oxygen species in TNF-alpha mediated activation of the transcription factor NF-kappaB in canine dermal fibroblasts |
Q34194765 | Ionizing radiation induces expression and binding activity of the nuclear factor kappa B |
Q37953457 | Is TNF involved in the progression of AIDS? |
Q36952188 | Is it time for a new paradigm for systemic cancer treatment? Lessons from a century of cancer chemotherapy |
Q24564866 | Isolation and characterization of the genomic human CD7 gene: structural similarity with the murine Thy-1 gene |
Q24313121 | Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3' enhancer and the immunoglobulin heavy-chain mu E1 site |
Q37995679 | It takes two to tango: IκBs, the multifunctional partners of NF-κB. |
Q24534726 | JFC1 is transcriptionally activated by nuclear factor-kappaB and up-regulated by tumour necrosis factor alpha in prostate carcinoma cells |
Q40418067 | Kainate-induced changes in gene expression in the rat hippocampus. |
Q34967823 | Kappa B enhancer-binding complexes that do not contain NF-kappa B are developmentally regulated in mammalian brain |
Q42088673 | Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages |
Q61816324 | Knockdown of PHF5A Inhibits Migration and Invasion of HCC Cells via Downregulating NF-B Signaling |
Q44773980 | Kupffer cell stimulation in the isolated perfused rat liver triggers nuclear factor-kappaB DNA binding activity |
Q44131477 | Kupffer cells play an important role in the cytokine production and activation of nuclear factors of liver grafts from non-heart-beating donors |
Q35743804 | LKB1 inhibition of NF-κB in B cells prevents T follicular helper cell differentiation and germinal center formation |
Q37414197 | LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells |
Q45072273 | LPS Induced Acute Lung Injury Involves the NF-κB-mediated Downregulation of SOX18. |
Q40714680 | Lack of correlation between NF-kappaB activation and induction of programmed cell death in PC12 pheochromocytoma cells treated with 6-hydroxydopamine or the cannabinoid receptor 1-agonist CP55,940. |
Q30862704 | Light chain promoter regions in rainbow trout Oncorhynchus mykiss: function of a classical and an atypical Ig promoter. |
Q33685432 | Lineage-specific regulation of the vasoactive intestinal peptide gene in neuroblastoma cells is conferred by 5.2 kilobases of 5'-flanking sequence |
Q36654363 | Lipopolysaccharide induction of tissue factor gene expression in monocytic cells is mediated by binding of c-Rel/p65 heterodimers to a kappa B-like site |
Q36352097 | Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expression |
Q42477868 | Lipopolysaccharide-induced E-selectin expression requires continuous presence of LPS and is inhibited by bactericidal/permeability-increasing protein |
Q36807858 | Lipopolysaccharide-induced NF-kappa B activation in mouse 70Z/3 pre-B lymphocytes is inhibited by mevinolin and 5'-methylthioadenosine: roles of protein isoprenylation and carboxyl methylation reactions |
Q36715019 | Lipopolysaccharide-unresponsive mutant pre-B-cell lines blocked in NF-kappa B activation |
Q36784310 | Localization of a repressive sequence contributing to B-cell specificity in the immunoglobulin heavy-chain enhancer |
Q36783237 | Loss of a phosphorylated form of transcription factor CREB/ATF in poliovirus-infected cells |
Q34559110 | Low-power laser irradiation suppresses inflammatory response of human adipose-derived stem cells by modulating intracellular cyclic AMP level and NF-κB activity |
Q40641439 | LyF-1, a transcriptional regulator that interacts with a novel class of promoters for lymphocyte-specific genes |
Q41238834 | Lymphoid specific gene expression of the adenovirus early region 3 promoter is mediated by NF-kappa B binding motifs |
Q40517596 | Lymphoid-specific transcriptional activation by components of the IgH enhancer: studies on the E2/E3 and octanucleotide elements |
Q41159609 | Lymphotoxin beta receptor triggering induces activation of the nuclear factor kappaB transcription factor in some cell types |
Q44654041 | MK-801 and 7-Ni attenuate the activation of brain NF-kappa B induced by LPS. |
Q73586025 | Maintaining gut homeostasis: the butyrate-NF-kappaB connection |
Q42182488 | Maintenance of NF-kappa B activity is dependent on protein synthesis and the continuous presence of external stimuli |
Q38350657 | Manipulation of distinct NFkappaB proteins alters interleukin-1beta-induced human rheumatoid synovial fibroblast prostaglandin E2 formation |
Q36829828 | Mapping of functional regions of murine retrovirus long terminal repeat enhancers: enhancer domains interact and are not independent in their contributions to enhancer activity |
Q28586183 | Master transcription factors determine cell-type-specific responses to TGF-β signaling |
Q33975148 | Matrix attachment region-dependent function of the immunoglobulin mu enhancer involves histone acetylation at a distance without changes in enhancer occupancy |
Q36354043 | Mechanism of suppression of lipopolysaccharide-driven B cell differentiation by anti-mu antibodies. Evidence for a trans-acting repressor of transcription |
Q38241249 | Mechanisms of viral-mediated trans-activation of transcription |
Q38328636 | Members of therel/NF-χB family of transcriptional regulatory proteins bind theHRAS1minisatellite DNA sequence |
Q85252750 | Meta-analysis of studies on the association between the NF-κB1-94ins/del ATTG promoter polymorphism and cancer |
Q37511434 | Metabolic consequences of sleep-disordered breathing |
Q38348149 | Metal ions alter lipopolysaccharide‐induced NFκB binding in monocytes |
Q43182276 | Metformin inhibits nuclear factor kappaB activation and decreases serum high-sensitivity C-reactive protein level in experimental atherogenesis of rabbits |
Q48383640 | Methamphetamine-induced increase in striatal NF-kappaB DNA-binding activity is attenuated in superoxide dismutase transgenic mice |
Q33778561 | MiDReG: a method of mining developmentally regulated genes using Boolean implications |
Q35640588 | MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-κB/IκBα negative feedback loop |
Q37995687 | MicroRNAs, new effectors and regulators of NF-κB. |
Q49912101 | Microenvironment-induced CD44v6 promotes early disease progression in chronic lymphocytic leukemia |
Q40222316 | Microtubules are required for NF-kappaB nuclear translocation in neuroblastoma IMR-32 cells: modulation by zinc |
Q28397259 | Mitochondria and reactive oxygen species: physiology and pathophysiology |
Q54045243 | Mitogen-activated protein kinase, ERK1/2, is essential for the induction of vascular endothelial growth factor by ionizing radiation mediated by activator protein-1 in human glioblastoma cells. |
Q38314105 | Modified binding of proteins from calcitonin-negative tumor cells to the neuroendocrine-specific CANNTG motif of the calcitonin gene |
Q53860042 | Modulation of NF-kappaB activity by exchange of dimers. |
Q35709298 | Modulation of NF-κB-dependent gene transcription using programmable DNA minor groove binders |
Q59352162 | Modulation of the NF-κB signaling pathway by the HIV-2 envelope glycoprotein and its incomplete BST-2 antagonism |
Q42044806 | Modulation of transcription factor NF-kappaB by enantiomers of the nonsteroidal drug ibuprofen |
Q89538271 | Molecular Mechanisms of Anticancer Activities of Puerarin |
Q36825080 | Molecular analysis of the differential hepatic expression of rat kininogen family genes |
Q40569396 | Molecular analysis of the interaction between an enhancer binding factor and its DNA target |
Q36316830 | Molecular basis of a multiple lymphokine deficiency in a patient with severe combined immunodeficiency |
Q39690880 | Molecular biological definition of the prothymocyte: problems of commitment and lineage promiscuity |
Q33916370 | Molecular characterizations of a novel putative DNA-binding protein LvDBP23 in marine shrimp L. vannamei tissues and molting stages |
Q35019648 | Molecular cloning of a zinc finger protein which binds to the heptamer of the signal sequence for V(D)J recombination. |
Q29620537 | Molecular cloning of an enhancer binding protein: isolation by screening of an expression library with a recognition site DNA |
Q38330735 | Molecular cloning of the promoter of the gene encoding the Rhesus monkey beta-amyloid precursor protein: structural characterization and a comparative study with other species. |
Q40703735 | Molecular mechanisms for lipopolysaccharide-induced biphasic activation of nuclear factor-kappa B (NF-kappa B). |
Q37074105 | Molecular pincers: antibody-based homogeneous protein sensors |
Q40942551 | Monoclonal anti-endothelial cell antibodies from a patient with Takayasu arteritis activate endothelial cells from large vessels |
Q89927186 | Moving towards a systems-based classification of innate immune-mediated diseases |
Q34614244 | Mucosal and enterocyte IL-6 production during sepsis and endotoxemia--role of transcription factors and regulation by the stress response |
Q37403234 | Multimerization of AAGTGA and GAAAGT generates sequences that mediate virus inducibility by mimicking an interferon promoter element |
Q48270366 | Multiple elements in the promoter of granulocyte colony-stimulating factor gene regulate its constitutive expression in human carcinoma cells |
Q36924647 | Multiple functional motifs in the chicken U1 RNA gene enhancer |
Q36090467 | Multiple mechanisms are implicated in the regulation of NF-kappa B activity during human cytomegalovirus infection |
Q41343956 | Multiple nuclear proteins in liver cells are bound to hepatitis B virus enhancer element and its upstream sequences |
Q35804109 | Multiple protein-DNA interactions in the TATAA-less mouse thymidylate synthase promoter |
Q38335469 | Multiple sets of adjacent μE1 and oct-1 binding sites upstream of the pseudorabies virus immediate-early gene promoter |
Q35691302 | Musca domestica pupae lectin improves the immunomodulatory activity of macrophages by activating nuclear factor-κB. |
Q35229584 | Mutant analysis of protein interactions with a nuclear factor I binding site in the SL3-3 virus enhancer |
Q40547392 | Mutational analysis of the contribution of sequence motifs within the IgH enhancer to tissue specific transcriptional activation |
Q38344348 | Mutations in two regions upstream of the A gamma globin gene canonical promoter affect gene expression |
Q33641257 | Mutations that disrupt DNA binding and dimer formation in the E47 helix-loop-helix protein map to distinct domains |
Q36238400 | Myocardial NF-κB activation is essential for zebrafish heart regeneration. |
Q35098367 | Myofibroblast differentiation is induced in keratinocyte-fibroblast co-cultures and is antagonistically regulated by endogenous transforming growth factor-beta and interleukin-1 |
Q24298140 | Myotrophin-kappaB DNA interaction in the initiation process of cardiac hypertrophy |
Q71699031 | N,N,N-trimethylsphingosine inhibits interleukin-1 beta-induced NF-kappa B activation and consequent E-selectin expression in human umbilical vein endothelial cells |
Q48485930 | N-acetyl-serotonin (normelatonin) and melatonin protect neurons against oxidative challenges and suppress the activity of the transcription factor NF-kappaB. |
Q64377363 | NF-?B-dependent gene expression of proinflammatory cytokines in T24 cells: possible role in interstitial cystitis |
Q28505819 | NF-kappa B RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses |
Q34277988 | NF-kappa B activates prostate-specific antigen expression and is upregulated in androgen-independent prostate cancer |
Q40874291 | NF-kappa B activates the HIV promoter in neurons |
Q35971557 | NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis |
Q38342724 | NF-kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation |
Q40884567 | NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. |
Q36709527 | NF-kappa B as a therapeutic target in neurodegenerative diseases |
Q38341645 | NF-kappa B as inducible transcriptional activator of the granulocyte-macrophage colony-stimulating factor gene |
Q36766907 | NF-kappa B binds within a region required for B-cell-specific expression of major histocompatibility complex class II gene E alpha d |
Q47880332 | NF-kappa B is activated and ICAM-1 gene expression is upregulated during reoxygenation of human brain endothelial cells |
Q40896004 | NF-kappa B is required for H-ras oncogene induced abnormal cell proliferation and tumorigenesis |
Q24629772 | NF-kappa B p100 (Lyt-10) is a component of H2TF1 and can function as an I kappa B-like molecule |
Q33676218 | NF-kappa B protein purification from bovine spleen: nucleotide stimulation and binding site specificity |
Q28646361 | NF-kappa B subunit-specific regulation of the interleukin-8 promoter |
Q41604208 | NF-kappa B-like factors mediate interleukin 1 induction of c-myc gene transcription in fibroblasts |
Q41435410 | NF-kappa B/Rel family members are physically associated phosphoproteins |
Q41069842 | NF-kappa B/Rel family members regulating the ICAM-1 promoter in monocytic THP-1 cells. |
Q34428983 | NF-kappa B: a crucial transcription factor for glial and neuronal cell function |
Q33927973 | NF-kappa B: a family of inducible and differentially expressed enhancer-binding proteins in human T cells |
Q29618566 | NF-kappa B: ten years after |
Q31911355 | NF-kappaB activation by N-CAM and cytokines in astrocytes is regulated by multiple protein kinases and redox modulation |
Q43954097 | NF-kappaB activation in non-parenchymal liver cells after partial hepatectomy in rats: possible involvement in expression of heparin-binding epidermal growth factor-like growth factor. |
Q37292774 | NF-kappaB activity marks cells engaged in receptor editing |
Q33699422 | NF-kappaB and apoptosis in mammary epithelial cells |
Q36984251 | NF-kappaB and cancer-identifying targets and mechanisms |
Q36617102 | NF-kappaB and cytokines |
Q36925725 | NF-kappaB and the intestine: friend or foe? |
Q34720640 | NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions. |
Q35196538 | NF-kappaB in pancreatic cancer |
Q37278416 | NF-kappaB regulates androgen receptor expression and prostate cancer growth |
Q37480036 | NF-kappaB regulation: the nuclear response |
Q47598860 | NF-kappaB signaling in the aging process |
Q37293337 | NF-kappaB signaling pathway and its therapeutic implications in human diseases |
Q36631434 | NF-kappaB signaling: pros and cons of altering NF-kappaB as a therapeutic approach |
Q34013841 | NF-kappaB transcription factors: critical regulators of hematopoiesis and neuronal survival |
Q33930920 | NF-kappaB/rel/IkappaB: implications in gastrointestinal diseases |
Q53668226 | NF-kappaB: a therapeutic target in inflammatory diseases. |
Q24293000 | NF-{kappa}B is transported into the nucleus by importin {alpha}3 and importin {alpha}4 |
Q90287011 | NF-κB Activation Promotes Alphavirus Replication in Mature Neurons |
Q44429808 | NF-κB activation by oxidative stress and inflammation suppresses contractility in colonic circular smooth muscle cells |
Q33632205 | NF-κB activation-induced anti-apoptosis renders HER2-positive cells drug resistant and accelerates tumor growth |
Q50508300 | NF-κB activity in perinatal brain during infectious and hypoxic-ischemic insults revealed by a reporter mouse. |
Q26777974 | NF-κB and HIF crosstalk in immune responses |
Q35347976 | NF-κB and STAT3 - key players in liver inflammation and cancer |
Q37995696 | NF-κB and the link between inflammation and cancer |
Q57203665 | NF-κB as an emerging target in atopy |
Q89730656 | NF-κB c-Rel Dictates the Inflammatory Threshold by Acting as a Transcriptional Repressor |
Q35806773 | NF-κB in Aging and Disease |
Q88968262 | NF-κB in Oxidative Stress |
Q38359190 | NF-κB in cancer therapy. |
Q27007045 | NF-κB in cellular senescence and cancer treatment |
Q27021276 | NF-κB in inflammation and renal diseases |
Q64998338 | NF-κB p65 promotes ovarian cancer cell proliferation and migration via regulating mortalin. |
Q26859097 | NF-κB regulation: lessons from structures |
Q38533864 | NF-κB signaling in B-1 cell development |
Q38025541 | NF-κB signaling pathways: role in nervous system physiology and pathology |
Q34249196 | NF-κB transcriptional activity is modulated by FK506-binding proteins FKBP51 and FKBP52: a role for peptidyl-prolyl isomerase activity. |
Q38478625 | NF-κB, a hot topic in biochemical and medical studies in China |
Q34138728 | NF-κB, an active player in human cancers |
Q49594691 | NF-κB, inflammation, immunity and cancer: coming of age. |
Q55024984 | NF-κB-Mediated Inflammation in the Pathogenesis of Intracranial Aneurysm and Subarachnoid Hemorrhage. Does Autophagy Play a Role? |
Q56029439 | NF-κB-mediated Induction ofmdr1bExpression by Insulin in Rat Hepatoma Cells |
Q91657956 | NF-κB/Rel Transcription Factors in Pancreatic Cancer: Focusing on RelA, c-Rel, and RelB |
Q43518751 | NF-κB: Much Learned, Much to Learn |
Q37706069 | NFKB1 -94insertion/deletion ATTG polymorphism and cancer risk: Evidence from 50 case-control studies |
Q41430113 | NFKB1/NFKBIa polymorphisms are associated with the progression of cervical carcinoma in HPV-infected postmenopausal women from rural area |
Q38668336 | NFKB1: a suppressor of inflammation, ageing and cancer |
Q74633719 | NFkappaB polymorphisms and susceptibility to type 1 diabetes |
Q44527114 | NFkappaB regulates plasma apolipoprotein A-I and high density lipoprotein cholesterol through inhibition of peroxisome proliferator-activated receptor alpha |
Q64108186 | NFκB and Kidney Injury |
Q58605654 | Nafamostat Mesilate Enhances the Radiosensitivity and Reduces the Radiation-Induced Invasive Ability of Colorectal Cancer Cells |
Q36843653 | Natural Agents Used in Chemoprevention of Aerodigestive and GI Cancers |
Q26775036 | Natural Products as Tools for Defining How Cellular Metabolism Influences Cellular Immune and Inflammatory Function during Chronic Infection |
Q55352989 | Natural cyclopeptide RA-V inhibits the NF-κB signaling pathway by targeting TAK1. |
Q64110798 | Natural gypenosides: targeting cancer through different molecular pathways |
Q33783417 | Naturally occurring human immunodeficiency virus type 1 long terminal repeats have a frequently observed duplication that binds RBF-2 and represses transcription |
Q36843747 | Negative regulation contributes to tissue specificity of the immunoglobulin heavy-chain enhancer |
Q37610921 | Negative regulation of human immunodeficiency virus type 1 expression in monocytes: role of the 65-kDa plus 50-kDa NF-kappa B dimer |
Q40650679 | Negative regulation of the human polyomavirus BK enhancer involves cell-specific interaction with a nuclear repressor |
Q36686575 | Negative regulation of the major histocompatibility complex class I enhancer in adenovirus type 12-transformed cells via a retinoic acid response element |
Q38363926 | Nepsilon-(Carboxymethyl)lysine induces gamma-glutamylcysteine synthetase in RAW264.7 cells |
Q27004226 | Neuroinflammation in Alzheimer's disease |
Q34074190 | Neuroinflammatory signaling upregulation in Alzheimer's disease |
Q28295723 | Neurotransporters: Regulation, involvement in neurotoxicity, and the usefulness of antisense nucleic acids |
Q37602880 | Never say die: survival signaling in large granular lymphocyte leukemia |
Q36753487 | New B-lymphocyte-specific enhancer-binding protein |
Q23923136 | New insights into the role of nuclear factor-KB, a ubiquitous transcription factor in the initiation of diseases |
Q38339649 | Nitric oxide inhibits Oct-1 DNA binding activity in cultured vascular smooth muscle cells |
Q28732768 | Non inflammatory boronate based glucose-responsive insulin delivery systems |
Q38224263 | Non-conventional functions for NF-κB members: the dark side of NF-κB. |
Q35149531 | Noncanonical NF-kappaB regulates inducible costimulator (ICOS) ligand expression and T follicular helper cell development |
Q33995197 | Novel IkappaB alpha proteolytic pathway in WEHI231 immature B cells |
Q38305549 | Novel NF-κB inhibitors: a patent review (2011 - 2014). |
Q61796703 | Novel function of PiT1/SLC20A1 in LPS-related inflammation and wound healing |
Q69187156 | Novel region within the V kappa gene promoter is responsible for tissue and stage-specific expression of immunoglobulin genes in human lymphoid neoplasms |
Q28578756 | Novel target sequences for Pax-6 in the brain-specific activating regions of the rat aldolase C gene |
Q92009746 | Nuclear Factor κB Signaling and Its Related Non-coding RNAs in Cancer Therapy |
Q41767515 | Nuclear Factor κB and Adenosine Receptors: Biochemical and Behavioral Profiling |
Q41020142 | Nuclear expression of the 50- and 65-kD Rel-related subunits of nuclear factor-kappa B is differentially regulated in human monocytic cells |
Q44020836 | Nuclear factor (NF)-kappa B blockade attenuates but does not abrogate LPS-mediated interleukin (IL)-1 beta biosynthesis in alveolar epithelial cells |
Q36400158 | Nuclear factor (NF)-kappa B2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses |
Q38346397 | Nuclear factor NF-kappa B can interact functionally with its cognate binding site to provide lymphoid-specific promoter function |
Q36684871 | Nuclear factor kappa B activates proenkephalin transcription in T lymphocytes |
Q47975100 | Nuclear factor kappa B dependent induction of gamma glutamylcysteine synthetase by ionizing radiation in T98G human glioblastoma cells |
Q41380813 | Nuclear factor kappa B functions as a negative regulator for the rat androgen receptor gene and NF-kappa B activity increases during the age-dependent desensitization of the liver |
Q40825105 | Nuclear factor kappa B, a mediator of lipopolysaccharide effects |
Q37811704 | Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB): a new potential therapeutic target in atherosclerosis? |
Q40842233 | Nuclear factor kappaB/p49 is a negative regulatory factor in nerve growth factor-induced choline acetyltransferase promoter activity in PC12 cells |
Q40282747 | Nuclear factor-kB signaling pathway constitutively activated in esophageal squamous cell carcinoma cell lines and inhibition of growth of cells by small interfering RNA. |
Q37958061 | Nuclear factor-kappa B inhibitors; a patent review (2006-2010). |
Q41598098 | Nuclear factor-kappa B. |
Q36516285 | Nuclear factor-kappaB as a hormonal intracellular signaling molecule: focus on angiotensin II-induced cardiovascular and renal injury |
Q35741937 | Nuclear factor-kappaB modulation as a therapeutic approach in hematologic malignancies |
Q48298914 | Nuclear factor-kappaB/Rel proteins: a point of convergence of signalling pathways relevant in neuronal function and dysfunction |
Q35791198 | Nuclear factor-kappaB: its role in health and disease |
Q37904904 | Nuclear factor-κB: a key regulator in health and disease of lungs |
Q40566068 | Nuclear factors binding to the human immunoglobulin heavy-chain gene enhancer |
Q33934527 | Nuclear factors that bind two regions important to transcriptional activity of the simian immunodeficiency virus long terminal repeat |
Q35347865 | Nuclear initiated NF-κB signaling: NEMO and ATM take center stage |
Q36120445 | Nuclear proteins from lactating mammary glands bind to the promoter of a milk protein gene |
Q37484641 | Nuclear proteins interacting with the promoter region of the human granulocyte/macrophage colony-stimulating factor gene |
Q35175282 | Nuclear transcription factor-kappaB in Hodgkin's disease |
Q24337591 | Nuclear uptake control of NF-kappa B by MAD-3, an I kappa B protein present in the nucleus |
Q30011272 | Nucleotide sequence and genomic organization of feline immunodeficiency virus |
Q34885671 | O-GlcNAcylation and Inflammation: A Vast Territory to Explore |
Q37338854 | Old target new approach: an alternate NF-kappaB activation pathway via translation inhibition |
Q33556692 | Oligonucleotide that binds nuclear factor NF-kappa B acts as a lymphoid-specific and inducible enhancer element |
Q35025834 | On the role of proteasomes in cell biology and proteasome inhibition as a novel frontier in the development of immunosuppressants |
Q40977712 | Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway. |
Q24301532 | Oncoprotein p28 GANK binds to RelA and retains NF-kappaB in the cytoplasm through nuclear export |
Q41350080 | One cell-specific and three ubiquitous nuclear proteins bind in vitro to overlapping motifs in the domain B1 of the SV40 enhancer |
Q34074249 | One path to cell death in the nervous system |
Q40389724 | Only two of the four sites of interaction with nuclear factors within the Xenopus U2 gene promoter are necessary for efficient transcription |
Q35493964 | Opposing roles of NF-κB in anti-cancer treatment outcome unveiled by cross-species investigations |
Q39545212 | Origin and diversification of anti-DNA antibodies |
Q48003020 | Overexpressed nuclear factor-kappaB can participate in endogenous C-reactive protein induction, and enhances the effects of C/EBPbeta and signal transducer and activator of transcription-3. |
Q40966176 | Overexpression of RelA causes G1 arrest and apoptosis in a pro-B cell line |
Q54318936 | Overexpression of the nuclear factor-kappa B (p65) in association with local failure in patients with head and neck carcinoma undergong radiotherapy or chemoradiotherapy. |
Q36828695 | Overlapping octamer and TAATGARAT motifs in the VF65-response elements in herpes simplex virus immediate-early promoters represent independent binding sites for cellular nuclear factor III |
Q38342514 | Oxidant-induced activation of nuclear factor-kappa B in cultured guinea pig gastric epithelial cells |
Q48681818 | Oxidative stress and cellular pathways of asthma and inflammation: Therapeutic strategies and pharmacological targets |
Q34756509 | Oxygen homeostasis, thiol equilibrium and redox regulation of signalling transcription factors in the alveolar epithelium. |
Q24802444 | Oxygen-sensing mechanisms and the regulation of redox-responsive transcription factors in development and pathophysiology |
Q40259515 | Ozone enhances diesel exhaust particles (DEP)-induced interleukin-8 (IL-8) gene expression in human airway epithelial cells through activation of nuclear factors- kappaB (NF-kappaB) and IL-6 (NF-IL6). |
Q42076844 | Ozone preconditioning and exposure to ketamine attenuates hepatic inflammation in septic rats |
Q92883594 | PLCE1 promotes myocardial ischemia-reperfusion injury in H/R H9c2 cells and I/R rats by promoting inflammation |
Q34750033 | PU.1 and C/EBP(alpha) synergistically program distinct response to NF-kappaB activation through establishing monocyte specific enhancers |
Q37635523 | PU.1 and an HLH family member contribute to the myeloid-specific transcription of the Fc gamma RIIIA promoter |
Q38305468 | PU.1-mediated transcription is enhanced by HMG-I(Y)-dependent structural mechanisms |
Q34275992 | Pathogenesis of rheumatoid arthritis: the role of synoviocytes |
Q37995569 | Peroxisome proliferator-activated receptor gamma (PPAR-γ) and neurodegenerative disorders |
Q34934915 | Pharmaco-redox regulation of cytokine-related pathways: from receptor signaling to pharmacogenomics |
Q36441438 | Pharmacogenetics of rheumatoid arthritis: Potential targets from susceptibility genes and present therapies |
Q37163274 | Phenanthrene-based tylophorine-1 (PBT-1) inhibits lung cancer cell growth through the Akt and NF-kappaB pathways |
Q39301230 | Phenotype gene expression differences between resistant and susceptible salmon families to IPNV. |
Q40671496 | Phorbol ester enhances human immunodeficiency virus-promoted gene expression and acts on a repeated 10-base-pair functional enhancer element |
Q40116527 | Phorbol ester-inducible T-cell-specific expression of variant mouse mammary tumor virus long terminal repeats |
Q40647203 | Phosphorylation of NF-kappaB proteins by cyclic GMP-dependent kinase. A noncanonical pathway to NF-kappaB activation |
Q33863591 | Photoaffinity labeling of transcription factors by DNA-templated crosslinking |
Q92815227 | Phycocyanin Exerts Anti-Proliferative Effects through Down-Regulating TIRAP/NF-κB Activity in Human Non-Small Cell Lung Cancer Cells |
Q41702876 | Physiological significance of recombination-activating gene 1 in neuronal death, especially optic neuropathy |
Q38560204 | Phytoconstituents as apoptosis inducing agents: strategy to combat cancer |
Q24294125 | Pirin is an iron-dependent redox regulator of NF-κB |
Q86846033 | Plant gene expression in response to pathogens |
Q38296767 | Platelet-activating factor stimulates transcription of the heparin-binding epidermal growth factor-like growth factor in monocytes. Correlation with an increased kappa B binding activity |
Q41182024 | Polymorphisms within Genes Involved in Regulation of the NF-κB Pathway in Patients with Rheumatoid Arthritis. |
Q91789128 | Pomegranate Juice Diminishes The Mitochondria-Dependent Cell Death And NF-kB Signaling Pathway Induced By Copper Oxide Nanoparticles On Liver And Kidneys Of Rats |
Q41933791 | Positive and negative regulation of immunoglobulin gene expression by a novel B-cell-specific enhancer element |
Q34379529 | Positive and negative regulation of nuclear factor-kappaB-mediated transcription by IkappaB-zeta, an inducible nuclear protein |
Q44031567 | Possible participation of intracellular platelet-activating factor in NF-kappaB activation in rat peritoneal macrophages. |
Q41008741 | Possible stage-specific function of NF-kappaB during pre-B cell differentiation |
Q43572303 | Post-transcriptional regulation of complement C4 in low C4-producing strain of mouse |
Q39888799 | Post-translational and transcriptional regulation of glycolipid glycosyltransferase genes in apoptotic breast carcinoma cells: VII. Studied by DNA-microarray after treatment with L-PPMP. |
Q37959267 | Potential roles of the NFκB and glutathione pathways in mature human erythrocytes. |
Q41644824 | Pre-B lymphocyte-specific transcriptional control of the mouse VpreB gene |
Q53597251 | Preconditioning with mono and polyunsaturated fatty acids and low-intensity electrical stimulation. Effects on skin repair in rats. |
Q34106909 | Presentation at the National Asthma Campaign International Congress, June 1999. Controlling the inflammatory response through transcriptional mechanisms |
Q38928538 | Primate Lentiviruses Modulate NF-κB Activity by Multiple Mechanisms to Fine-Tune Viral and Cellular Gene Expression |
Q42234301 | Probiotics and ileitis: could augmentation of TNF/NFκB activity be the answer? |
Q38322797 | Promoter activity of the beta-amyloid precursor protein gene is negatively modulated by an upstream regulatory element |
Q38313406 | Promoter analysis of the gene encoding the I kappa B-alpha/MAD3 inhibitor of NF-kappa B: positive regulation by members of the rel/NF-kappa B family |
Q36922184 | Promoter and enhancer elements from the rat elastase I gene function independently of each other and of heterologous enhancers |
Q41352989 | Promoter and enhancer elements in the rearranged alpha chain gene of the human T cell receptor. |
Q41345323 | Promoter interaction of the E1A-inducible factor E2F and its potential role in the formation of a multi-component complex |
Q28393150 | Propofol's effect on the sciatic nerve: Harmful or protective? |
Q77370143 | Protective role of glutathione synthesis in response to oxidized low density lipoprotein in human vascular endothelial cells |
Q36802382 | Protein kinase A-dependent binding of a nuclear factor to the 21-base-pair repeat of the human T-cell leukemia virus type I long terminal repeat |
Q41643289 | Protein kinases negatively affect nuclear factor-kappa B activation by tumor necrosis factor-alpha at two different stages in promyelocytic HL60 cells |
Q34380242 | Protein-binding site at the immunoglobulin mu membrane polyadenylylation signal: possible role in transcription termination |
Q34628659 | Protein-nucleotide contacts in the immunoglobulin heavy-chain promoter region |
Q36766668 | Proteins binding to site C2 (muE3) in the immunoglobulin heavy-chain enhancer exist in multiple oligomeric forms |
Q45775847 | Proteins specifically binding to the 3' untranslated region of hepatitis A virus RNA in persistently infected cells |
Q33447166 | Proteomic screening of variola virus reveals a unique NF-kappaB inhibitor that is highly conserved among pathogenic orthopoxviruses |
Q40462999 | Proto‐oncogenes and oncogenes in epidermal neoplasia |
Q36923048 | Proviral sequences that restrict retroviral expression in mouse embryonal carcinoma cells |
Q41545090 | Purification and characterization of a 59-kilodalton protein that specifically binds to NF-kappa B-binding motifs of the defense protein genes of Sarcophaga peregrina (the flesh fly). |
Q36709682 | Purification and cloning of interferon-stimulated gene factor 2 (ISGF2): ISGF2 (IRF-1) can bind to the promoters of both beta interferon- and interferon-stimulated genes but is not a primary transcriptional activator of either |
Q36776782 | Purification and properties of the Rous sarcoma virus internal enhancer binding factor |
Q42735234 | Purification of the human immunodeficiency virus type 1 enhancer and TAR binding proteins EBP-1 and UBP-1. |
Q24312701 | Purification of the major histocompatibility complex class I transcription factor H2TF1. The full-length product of the nfkb2 gene |
Q36849557 | Purified mu EBP-E binds to immunoglobulin enhancers and promoters |
Q47895591 | Pyrrolidine dithiocarbamate attenuates alcohol-induced leukocyte-endothelial cell interaction and cerebral vascular damage in rats: possible role of activation of transcription factor NF-kappaB in alcohol brain pathology |
Q35361444 | Qualitative changes in the subunit composition of kappa B-binding complexes during murine B-cell differentiation |
Q55080415 | Quantitative analysis reveals crosstalk mechanisms of heat shock-induced attenuation of NF-κB signaling at the single cell level. |
Q37183960 | Quercetin: a potential natural drug for adjuvant treatment of rheumatoid arthritis |
Q22003884 | RP58 associates with condensed chromatin and mediates a sequence-specific transcriptional repression |
Q33837271 | Rapid activation by interferon alpha of a latent DNA-binding protein present in the cytoplasm of untreated cells |
Q36817938 | Rapid induction in regenerating liver of RL/IF-1 (an I kappa B that inhibits NF-kappa B, RelB-p50, and c-Rel-p50) and PHF, a novel kappa B site-binding complex |
Q38290480 | Reactive oxygen species accelerate production of vascular endothelial growth factor by advanced glycation end products in RAW264.7 mouse macrophages |
Q33795121 | Real-time monitoring of nuclear factor kappaB activity in cultured cells and in animal models. |
Q47143199 | Recent Advances in Comprehending the Signaling Pathways Involved in the Progression of Breast Cancer |
Q28082629 | Recent advances on viral manipulation of NF-κB signaling pathway |
Q38309890 | Recognition sequence of a highly conserved DNA binding protein RBP-J kappa |
Q44117518 | Redox regulation of pro-inflammatory cytokines and IkappaB-alpha/NF-kappaB nuclear translocation and activation |
Q64078199 | Regulation Mechanism of Long Noncoding RNAs in Colon Cancer Development and Progression |
Q36735093 | Regulation and a possible stage-specific function of Oct-2 during pre-B-cell differentiation |
Q39869047 | Regulation of I kappa B alpha and p105 in monocytes and macrophages persistently infected with human immunodeficiency virus |
Q56967374 | Regulation of IgG production by suppressor FcγRII+ T hybridomas |
Q40022914 | Regulation of IkappaB beta in WEHI 231 mature B cells |
Q21296830 | Regulation of IkappaBalpha function and NF-kappaB signaling: AEBP1 is a novel proinflammatory mediator in macrophages |
Q36619370 | Regulation of JC virus expression in B lymphocytes |
Q35225874 | Regulation of Muscle Cell Growth and Differentiation by the Myod Family of Helix-Loop-Helix Proteins |
Q41506409 | Regulation of NF-kappa B and disease control: identification of a novel serine kinase and thioredoxin as effectors for signal transduction pathway for NF-kappa B activation |
Q37995682 | Regulation of NF-κB by deubiquitinases |
Q37995680 | Regulation of NF-κB by ubiquitination and degradation of the IκBs |
Q30416476 | Regulation of Rela/p65 and endothelial cell inflammation by proline-rich tyrosine kinase 2. |
Q37995693 | Regulation of cell death and autophagy by IKK and NF-κB: critical mechanisms in immune function and cancer |
Q34182208 | Regulation of constitutive p50/c-Rel activity via proteasome inhibitor-resistant IkappaBalpha degradation in B cells. |
Q38361270 | Regulation of expression of the rat serine protease inhibitor 2.3 gene by glucocorticoids and interleukin-6. A complex and unusual interplay between positive and negative cis-acting elements |
Q33530101 | Regulation of gene expression in hepatic cells by the mammalian Target of Rapamycin (mTOR). |
Q69554937 | Regulation of hepatocyte gene expression: progress on the horizon |
Q52248159 | Regulation of human fetal hemoglobin gene expression. |
Q47911157 | Regulation of immunoglobulin light chain isotype expression |
Q33195463 | Regulation of immunoglobulin promoter activity by TFII-I class transcription factors |
Q41881846 | Regulation of interleukin 1 signalling through integrin binding and actin reorganization: disparate effects on NF-kappaB and stress kinase pathways. |
Q35841165 | Regulation of kappa immunoglobulin gene transcription in vitro |
Q53427787 | Regulation of keratinocyte growth factor expression in human endometrium: implications for hormonal carcinogenesis. |
Q43210885 | Regulation of maturation and activating potential in CD8+ versus CD8- dendritic cells following in vivo infection with vaccinia virus. |
Q28342819 | Regulation of mouse CYP1A1 gene expression by dioxin: requirement of two cis-acting elements during induction |
Q41702567 | Regulation of the antibody class switch to IgA. |
Q33635420 | Regulation of the class II-associated invariant chain gene in normal and mutant B lymphocytes |
Q28609914 | Regulation of the mammalian alcohol dehydrogenase genes |
Q24598849 | Regulation of the mouse alpha A-crystallin gene: isolation of a cDNA encoding a protein that binds to a cis sequence motif shared with the major histocompatibility complex class I gene and other genes |
Q36350171 | Regulation of transcription of the human T cell antigen receptor delta chain gene. A T lineage-specific enhancer element is located in the J delta 3-C delta intron |
Q28645847 | Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B |
Q40874071 | Regulatory elements in the immunoglobulin kappa locus induce c-myc activation and the promoter shift in Burkitt's lymphoma cells |
Q40127477 | Regulatory elements within the murine leukemia virus enhancer regions mediate glucocorticoid responsiveness |
Q29615580 | Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation |
Q40806596 | RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A |
Q42153632 | RelA: a tale of a stitch in time |
Q34524628 | RelAp43, a member of the NF-κB family involved in innate immune response against Lyssavirus infection |
Q33348553 | RelB-dependent stromal cells promote T-cell leukemogenesis |
Q33684251 | Repeated B motifs in the human immunodeficiency virus type I long terminal repeat enhancer region do not exhibit cooperative factor binding |
Q78049289 | Required and nonessential functions of nuclear factor-kappa B in bone cells |
Q41643389 | Requirement of phosphatidylinositol 3-kinase activity for bradykinin stimulation of NF-kappaB activation in cultured human epithelial cells |
Q42488593 | Resveratrol modulates intestinal morphology and HSP70/90, NF-κB and EGF expression in the jejunal mucosa of black-boned chickens on exposure to circular heat stress |
Q24301668 | Ribosomal protein S3: a KH domain subunit in NF-kappaB complexes that mediates selective gene regulation |
Q35551066 | Rickettsia rickettsii infection of cultured human endothelial cells induces NF-kappaB activation |
Q38294141 | Role for NF-kappa B in the regulation of ferritin H by tumor necrosis factor-alpha |
Q92959413 | Role of NF-κB in Platelet Function |
Q64389423 | Role of RNF20 in cancer development and progression - a comprehensive review |
Q36364580 | Role of Rel-related factors in control of c-myc gene transcription in receptor-mediated apoptosis of the murine B cell WEHI 231 line |
Q48068590 | Role of a distal enhancer containing a functional NF-kappa B-binding site in lipopolysaccharide-induced expression of a novel alpha 1-antitrypsin gene |
Q36778892 | Role of activated nuclear factor-kappaB in the pathogenesis and therapy of squamous cell carcinoma of the head and neck |
Q41956727 | Role of ascorbate in the activation of NF-kappaB by tumour necrosis factor-alpha in T-cells |
Q46465276 | Role of neuroinflammation and latent transcription factors in pathogenesis of Parkinson's disease. |
Q35120883 | Role of nuclear factor κB-mediated inflammatory pathways in cancer-related symptoms and their regulation by nutritional agents |
Q46679333 | Role of the NF-kappaB signaling cascade and NF-kappaB-targeted genes in failing human hearts |
Q43061086 | Role of transcription factors in inflammatory lung diseases |
Q26752576 | Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches |
Q38567094 | Roles of the NF-κB Pathway in B-Lymphocyte Biology. |
Q30494316 | SLEEP DISORDERED BREATHING AND METABOLIC EFFECTS: EVIDENCE FROM ANIMAL MODELS |
Q58611348 | SNW1 as a novel transcriptional regulator of the NF-κB pathway |
Q40262359 | STAT3 is required but not sufficient for EGF receptor-mediated migration and invasion of human prostate carcinoma cell lines |
Q24791031 | Science review: Redox and oxygen-sensitive transcription factors in the regulation of oxidant-mediated lung injury: role for nuclear factor-kappaB |
Q24293705 | Selection of optimal kappa B/Rel DNA-binding motifs: interaction of both subunits of NF-kappa B with DNA is required for transcriptional activation |
Q33916866 | Separate elements control DJ and VDJ rearrangement in a transgenic recombination substrate |
Q33885892 | Sequence analysis and DNA-protein interactions within the 5' flanking region of the Ca2+/calmodulin-dependent protein kinase II alpha-subunit gene |
Q36717291 | Sequence elements required for activity of a murine major histocompatibility complex class II promoter bind common and cell-type-specific nuclear factors |
Q40520724 | Sequence requirement for specific interaction of an enhancer binding protein (EBP1) with DNA. |
Q37941058 | Sequence signals in eukaryotic upstream regions |
Q38318271 | Sequence-specific inhibition of a transcription factor by circular dumbbell DNA oligonucleotides |
Q48241846 | Sequencing of selected regions of the human immunoglobulin heavy-chain gene locus that completes the sequence from JH through the delta constant region |
Q41450875 | Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation |
Q33925031 | Serum amyloid A protein-related mRNA expression in herpes simplex virus type 2-transformed hamster cells |
Q41724478 | Signal transduction through NF-kappa B. |
Q40881293 | Signal-dependent and -independent degradation of free and NF-kappa B-bound IkappaBalpha |
Q28776784 | Signal-induced degradation of I(kappa)B(alpha): association with NF-kappaB and the PEST sequence in I(kappa)B(alpha) are not required |
Q40736577 | Signaling by the Mpl receptor involves IKK and NF-kappaB. |
Q35452032 | Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease |
Q42122113 | Signaling function of Na,K-ATPase induced by ouabain against LPS as an inflammation model in hippocampus. |
Q37694247 | Silencing of human immunodeficiency virus long terminal repeat expression by an adenovirus E1a mutant |
Q36958926 | Silencing of the expression of the immunoglobulin kappa gene in non-B cells |
Q35200773 | Single-nucleotide mutation matrix: a new model for predicting the NF-κB DNA binding sites |
Q45969491 | Site-specific binding of a nuclear factor to the carrot extensin gene is influenced by both ethylene and wounding. |
Q36836984 | Six distinct nuclear factors interact with the 75-base-pair repeat of the Moloney murine leukemia virus enhancer |
Q49364990 | Sodium fluoride induces apoptosis in mouse splenocytes by activating ROS-dependent NF-κB signaling |
Q48104189 | Sodium salicylate and 17beta-estradiol attenuate nuclear transcription factor NF-kappaB translocation in cultured rat astroglial cultures following exposure to amyloid A beta(1-40) and lipopolysaccharides |
Q48092080 | Sophisticated lessons from simple organisms: appreciating the value of curiosity-driven research |
Q24645001 | Specific NF-kappa B subunits act in concert with Tat to stimulate human immunodeficiency virus type 1 transcription |
Q35771896 | Specific inhibition of formation of transcription complexes by a calicheamicin oligosaccharide: a paradigm for the development of transcriptional antagonists |
Q44071784 | Sphingomyelinase and ceramide analogs induce vasoconstriction and leukocyte-endothelial interactions in cerebral venules in the intact rat brain: Insight into mechanisms and possible relation to brain injury and stroke |
Q91704213 | Stable intronic sequence RNAs (sisRNAs) are selected regions in introns with distinct properties |
Q36945326 | Staphylococcus aureus and derived exotoxins induce nuclear factor kappa B-like activity in murine bone marrow macrophages |
Q36115970 | Statistical Techniques Complement UML When Developing Domain Models of Complex Dynamical Biosystems. |
Q53269765 | Steroid treatment can inhibit nuclear localization of members of the NF-κB pathway in human disc cells stimulated with TNF-α. |
Q41105089 | Stimulation of interleukin-8 production by okadaic acid and vanadate in a human promyelocyte cell line, an HL-60 subline. Possible role of mitogen-activated protein kinase on the okadaic acid-induced NF-kappaB activation |
Q36791571 | Stimulation of the human immunodeficiency virus type 1 enhancer by the human T-cell leukemia virus type I tax gene product involves the action of inducible cellular proteins |
Q45948452 | Structural analyses of human developmentally regulated Vh3 genes. |
Q37816940 | Structural studies of NF-κB signaling |
Q24295016 | Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes |
Q44501302 | Structure and expression of mouse germline immunoglobulin γ3 heavy chain transcripts induced by the mitogen lipopolysaccharide |
Q42072324 | Structure and expression of the attacin genes in Hyalophora cecropia |
Q36550429 | Structure and expression of the guinea pig preproenkephalin gene: site-specific cleavage in the 3' untranslated region yields truncated mRNA transcripts in specific brain regions |
Q27641937 | Structure of NFAT1 bound as a dimer to the HIV-1 LTR kappa B element |
Q27730340 | Structure of the NF-kappa B p50 homodimer bound to DNA |
Q40516672 | Structure of the NF-kappa B transcription factor: a holistic interaction with DNA. |
Q36360932 | Structure of the mouse pore-forming protein (perforin) gene: analysis of transcription initiation site, 5' flanking sequence, and alternative splicing of 5' untranslated regions |
Q40774323 | Structure, function, and regulation of the chalcone synthase |
Q36866660 | Study of the E2 gene product of the cottontail rabbit papillomavirus reveals a common mechanism of transactivation among papillomaviruses |
Q51534923 | Subset of genes targeted by transcription factor NF-κB in TNFα-stimulated human HeLa cells. |
Q36796214 | Substitution of murine transthyretin (prealbumin) regulatory sequences into the Moloney murine leukemia virus long terminal repeat yields infectious virus with altered biological properties |
Q54115289 | Subunit-Specific Role of NF-κB in Cancer. |
Q34251052 | Synergistic activation of NF-{kappa}B by bacterial chemoattractant and TNF{alpha} is mediated by p38 MAPK-dependent RelA acetylation |
Q45764584 | Synthetic inhibitors of regulatory proteins involved in the signaling pathway of the replication of human immunodeficiency virus 1. |
Q36790901 | Systematic binding analysis of the insulin gene transcription control region: insulin and immunoglobulin enhancers utilize similar transactivators |
Q36356478 | T cell receptor beta gene has two downstream DNase I hypersensitive regions. Possible mechanisms of tissue- and stage-specific gene regulation |
Q40661178 | T-cell activation signals and human T-cell leukemia virus type I-encoded p40x protein activate the mouse granulocyte-macrophage colony-stimulating factor gene through a common DNA element |
Q33569344 | T-cell-specific expression of interleukin 2: evidence for a negative regulatory site |
Q33609443 | TNF stimulates expression of mouse MHC class I genes by inducing an NF kappa B-like enhancer binding activity which displaces constitutive factors |
Q46256350 | Targeting IκBNS in allergic asthma: where it resides, matters. |
Q38267049 | Targeting the NFκB signaling pathways for breast cancer prevention and therapy. |
Q36815430 | The -6.1-kilobase chicken lysozyme enhancer is a multifactorial complex containing several cell-type-specific elements. |
Q36866190 | The 65-kDa subunit of human NF-kappa B functions as a potent transcriptional activator and a target for v-Rel-mediated repression |
Q36231038 | The AP-1 site at -150 bp, but not the NF-kappa B site, is likely to represent the major target of protein kinase C in the interleukin 2 promoter |
Q36788821 | The COUP transcription factor binds to an upstream promoter element of the rat insulin II gene |
Q70521479 | The DNA-binding properties of an artificial 42-residue polypeptide derived from a natural repressor |
Q41361813 | The ER-overload response: activation of NF-kappa B. |
Q35687004 | The Effect of NF-κB Signalling Pathway on Expression and Regulation of Nacrein in Pearl Oyster, Pinctada fucata |
Q36830501 | The Epstein-Barr virus BMLF1 promoter contains an enhancer element that is responsive to the BZLF1 and BRLF1 transactivators |
Q41842515 | The Interface between BCR-ABL-Dependent and -Independent Resistance Signaling Pathways in Chronic Myeloid Leukemia. |
Q40079781 | The N-terminal ubiquitin-associated domain of Cezanne is crucial for its function to suppress NF-κB pathway |
Q24564833 | The NF-kappa B precursor p105 and the proto-oncogene product Bcl-3 are I kappa B molecules and control nuclear translocation of NF-kappa B |
Q36793914 | The NF-kappa B-binding site mediates phorbol ester-inducible transcription in nonlymphoid cells |
Q37672294 | The NF-kappaB family of transcription factors and its regulation |
Q33791263 | The NF-kappaB/Rel family of transcription factors in oncogenic transformation and apoptosis |
Q55030870 | The NIK of time for B cells. |
Q52548643 | The Rel family of eukaryotic transcription factors. |
Q34023268 | The Rel/NF-kappa B family: friend and foe. |
Q58729438 | The Role of the Transcription Factor Nuclear Factor-kappa B in Thyroid Autoimmunity and Cancer |
Q40820614 | The SV40 TC-II(kappa B) and the related H-2Kb enhansons exhibit different cell type specific and inducible proto-enhancer activities, but the SV40 core sequence and the AP-2 binding site have no enhanson properties |
Q40820623 | The SV40 TC-II(kappa B) enhanson binds ubiquitous and cell type specifically inducible nuclear proteins from lymphoid and non-lymphoid cell lines |
Q40646070 | The Xenopus laevis U2 gene distal sequence element (enhancer) is composed of four subdomains that can act independently and are partly functionally redundant |
Q42519829 | The ability of the inhibitory domain of the POU family transcription factor Oct-2 to interfere with promoter activation by different classes of activation domains is dependent upon the nature of the basal promoter elements |
Q36648227 | The bZIP transactivator of Epstein-Barr virus, BZLF1, functionally and physically interacts with the p65 subunit of NF-kappa B |
Q37845372 | The basic science of heart transplantation: important immune cell surface molecules |
Q28363797 | The biphasic immunoregulation of pyrimidylpiperazine (Y-40138) is IL-10 sensitive and requires NF-kappa B targeting in the alveolar epithelium |
Q28645819 | The c-rel protooncogene product c-Rel but not NF-kappa B binds to the intronic region of the human interferon-gamma gene at a site related to an interferon-stimulable response element |
Q36086609 | The c-rel protooncogene product represses NF-kappa B p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus |
Q36779415 | The cell-specific enhancer of the mouse transthyretin (prealbumin) gene binds a common factor at one site and a liver-specific factor(s) at two other sites |
Q38126565 | The complexity of NF-κB signaling in inflammation and cancer |
Q37700164 | The complicated role of NF-kappaB in T-cell selection. |
Q47167746 | The crossroads of breast cancer progression: insights into the modulation of major signaling pathways |
Q41082173 | The duplicated chalcone synthase genes C2 and Whp (white pollen) of Zea mays are independently regulated; evidence for translational control of Whp expression by the anthocyanin intensifying gene in |
Q37816327 | The early expression of some human autoantibody-associated heavy chain variable region genes is controlled by specific regulatory elements |
Q72997317 | The effect of humic acid on the adhesibility of neutrophils |
Q51124740 | The elevated activation of NFκB and AP-1 is correlated with differential regulation of Bcl-2 and associated with oral squamous cell carcinoma progression and resistance. |
Q28303889 | The human acute-phase serum amyloid A gene family: structure, evolution and expression in hepatoma cells |
Q72223508 | The human leukocyte antigen A2 interferon-stimulated response element consensus sequence binds a nuclear factor required for constitutive expression |
Q41694396 | The human t(1;19) translocation in pre-B ALL produces multiple nuclear E2A-Pbx1 fusion proteins with differing transforming potentials |
Q40818245 | The immunoglobulin kappa locus contains a second, stronger B-cell-specific enhancer which is located downstream of the constant region |
Q40885991 | The inducible transcription factor NF-kappa B: structure-function relationship of its protein subunits |
Q40678585 | The insulin and islet amyloid polypeptide genes contain similar cell-specific promoter elements that bind identical beta-cell nuclear complexes |
Q37374200 | The interleukin-1 receptor-associated kinase M selectively inhibits the alternative, instead of the classical NFkappaB pathway |
Q38323680 | The kappa B enhancer motifs in human immunodeficiency virus type 1 and simian virus 40 recognize different binding activities in human Jurkat and H9 T cells: evidence for NF-kappa B-independent activation of the kappa B motif |
Q24800100 | The kappa B transcriptional enhancer motif and signal sequences of V(D)J recombination are targets for the zinc finger protein HIVEP3/KRC: a site selection amplification binding study |
Q37825898 | The kinase NIK as a therapeutic target in multiple myeloma |
Q47071752 | The lesswright mutation activates Rel-related proteins, leading to overproduction of larval hemocytes in Drosophila melanogaster |
Q33733127 | The lncRNA n340790 accelerates carcinogenesis of thyroid cancer by regulating miR-1254 |
Q37596814 | The long non-coding RNA NKILA inhibits the invasion-metastasis cascade of malignant melanoma via the regulation of NF-ĸB. |
Q40891401 | The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line |
Q41581183 | The mouse Eb meiotic recombination hotspot contains a tissue-specific transcriptional enhancer |
Q68413209 | The mouse albumin promoter and a distal upstream site are simultaneously DNase I hypersensitive in liver chromatin and bind similar liver-abundant factors in vitro |
Q41035118 | The mutant plasmacytoma cell line S107 allows the identification of distinct pathways leading to NF-kappaB activation |
Q37384802 | The nfkb1 promoter is controlled by proteins of the Ets family |
Q33943227 | The nuclear factor kappa B (NF-kappa B): a potential therapeutic target for estrogen receptor negative breast cancers |
Q40419747 | The nucleotide sequence of the gene encoding the sperm specific histone subtype H2B-1 from the sea urchin Strongylocentrotus purpuratus |
Q34061332 | The oncoprotein Bcl-3 can facilitate NF-kappa B-mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites. |
Q48627114 | The origins of NF-κB. |
Q31076639 | The p50 subunit of NF-kappa B associates with the NF-IL6 transcription factor |
Q37156449 | The perils of gene patents |
Q35887836 | The pllaswoacfloma J558b lacks constitutivdy active NF-×B and is deficient in early response gene activation |
Q42442354 | The promoter of the human type I 5'-deiodinase gene--mapping of the transcription start site and identification of a DR+4 thyroid-hormone-responsive element |
Q40557945 | The rat albumin gene promoter is appropriately regulated in transient but not in stable transfections |
Q90621963 | The regulation of sequence specific NF-κB DNA binding and transcription by IKKβ phosphorylation of NF-κB p50 at serine 80 |
Q99241140 | The relationship between TRAF6 and tumors |
Q41159722 | The retinoblastoma gene product (Rb) induces binding of a conformationally inactive nuclear factor-kappaB. |
Q34405471 | The role of E2A-PBX1 in leukemogenesis |
Q40082839 | The role of IkappaBalpha in TNF-alpha-induced apoptosis in hepatic stellate cell line HSC-T6. |
Q34102964 | The role of NF-kappaB/IkappaB proteins in cancer: implications for novel treatment strategies |
Q26825502 | The role of NF-κB in the pathogenesis of glioma |
Q35627680 | The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: implications for therapy |
Q33963866 | The role of nuclear factor-kappaB essential modulator (NEMO) in B cell development and survival. |
Q43750943 | The sequence-specific DNA binding of NF-kappa B is reversibly regulated by the automodification reaction of poly (ADP-ribose) polymerase 1. |
Q36798712 | The state of cellular differentiation determines the activity of the adenovirus E1A enhancer element: evidence for negative regulation of enhancer function |
Q30193224 | The structure of the NF-kappa B p50:DNA-complex: a starting point for analyzing the Rel family. |
Q41644100 | The tetrameric structure of NF-mu NR provides a mechanism for cooperative binding to the immunoglobulin heavy chain mu enhancer |
Q36105771 | The transcription factor NF-kappaB as drug target |
Q40903441 | The ubiquitin-proteasome pathway: review of a novel intracellular mechanism of muscle protein breakdown during sepsis and other catabolic conditions |
Q28776191 | The upstream muscle-specific enhancer of the rat muscle creatine kinase gene is composed of multiple elements |
Q38327293 | The v-rel oncogene: insights into the mechanism of transcriptional activation, repression, and transformation |
Q34313863 | Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62 |
Q40598051 | Thioredoxin, a regulator of gene expression |
Q36788449 | Three sequence-specific DNA-protein complexes are formed with the same promoter element essential for expression of the rat somatostatin gene |
Q40606151 | Thrombospondin-1 mediates distal tubule hypertrophy induced by glycated albumin |
Q41338265 | Tissue-specific expression of the human growth hormone gene is conferred in part by the binding of a specific trans-acting factor |
Q36761748 | Tissue-specific transcription of the mouse alpha-fetoprotein gene promoter is dependent on HNF-1. |
Q89509415 | Toll-like Receptors from the Perspective of Cancer Treatment |
Q30500126 | Toll-like receptor 2-dependent NF-kappaB activation is involved in nontypeable Haemophilus influenzae-induced monocyte chemotactic protein 1 up-regulation in the spiral ligament fibrocytes of the inner ear. |
Q33598805 | Toll-like receptor signaling in cell proliferation and survival |
Q24624348 | Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses |
Q73985196 | Tosylphenylalanine chloromethyl ketone inhibits TNF-alpha mRNA synthesis in the presence of activated NF-kappa B in RAW 264.7 macrophages |
Q26771913 | Traditional Chinese medicine targeting apoptotic mechanisms for esophageal cancer therapy |
Q41241972 | Transactivation of anthocyanin biosynthetic genes following transfer of B regulatory genes into maize tissues |
Q34345156 | Transcription factor NF-kappaB as a potential biomarker for oxidative stress |
Q35208812 | Transcription factors activated in mammalian cells after clinically relevant doses of ionizing radiation |
Q37008654 | Transcription factors as therapeutic targets in lymphoid malignancies |
Q36795069 | Transcription from a murine T-cell receptor V beta promoter depends on a conserved decamer motif similar to the cyclic AMP response element |
Q37354312 | Transcription of the tumor necrosis factor alpha gene is rapidly induced by anti-immunoglobulin and blocked by cyclosporin A and FK506 in human B cells |
Q34983243 | Transcriptional Factor NF-κB as a Target for Therapy in Parkinson's Disease |
Q36827386 | Transcriptional activation of bovine leukemia virus in blood cells from experimentally infected, asymptomatic sheep with latent infections |
Q41614925 | Transcriptional activation of human (2'-5')oligoadenylate synthetase gene expression by the phorbol ester 12-O-tetradecanoyl-phorbol 13-acetate in type-I-interferon-treated HL-60 and HeLa cells |
Q41256218 | Transcriptional activation of the chicken lysozyme gene by NF-kappa Bp65 (RelA) and c-Rel, but not by NF-kappa Bp50. |
Q41110219 | Transcriptional and post-transcriptional mechanisms can regulate cell-specific expression of the human Pi-class glutathione S-transferase gene |
Q35895816 | Transcriptional profiling of antigen-dependent murine B cell differentiation and memory formation |
Q40769199 | Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer |
Q69235728 | Transcriptional regulation of immunoglobulin expression in a chronic lymphocytic leukemia cell line |
Q36789097 | Transcriptional regulation of neurogenesis: potential mechanisms in cerebral ischemia |
Q34344626 | Transcriptional regulation of the BCL-X gene by NF-kappaB is an element of hypoxic responses in the rat brain |
Q71743383 | Transcriptional regulation of the rat insulin-like growth factor-I gene involves metabolism-dependent binding of nuclear proteins to a downstream region |
Q36637878 | Transcriptional regulation via the NF-kappaB signaling module. |
Q36781976 | Transfection of an immunoglobulin kappa gene into mature human B lymphocytes |
Q40525261 | Transfer-RNA interferes with the uniform cleavage pattern of DNA by hydroxyl radicals |
Q88379121 | Tumor necrosis factor alfa and interleukin 1 alfa induced phosphorylation and degradation of inhibitory kappa B alpha are regulated by estradiol in endometrial cells |
Q38319685 | Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. |
Q29618096 | Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B |
Q33847436 | Tumor necrosis factor alpha induces proteins that bind specifically to kappa B-like enhancer elements and regulate interleukin 2 receptor alpha-chain gene expression in primary human T lymphocytes |
Q38339930 | Tumor necrosis factor alpha regulates expression of the major histocompatibility complex class II-associated invariant chain by binding of an NF-kappa B-like factor to a promoter element |
Q33779887 | Tumor necrosis factor alpha transcription in macrophages is attenuated by an autocrine factor that preferentially induces NF-kappaB p50. |
Q41760327 | Tumor necrosis factor-alpha induces a kappa B sequence-specific DNA-binding protein in human hepatoblastoma HepG2 cells |
Q38113724 | Tumor promoters: from chemicals to inflammatory proteins |
Q23912835 | Tumor promoting or tumor suppressing of NF-kB, a matter of cell context dependency |
Q36775267 | Two adjacent C/EBP-binding sequences that participate in the cell-specific expression of the mouse serum amyloid A3 gene |
Q40653250 | Two conserved essential motifs of the murine immunoglobulin lambda enhancers bind B-cell-specific factors |
Q38349354 | Two different factors bind to the alpha-domain of the polyoma virus enhancer, one of which also interacts with the SV40 and c-fos enhancers. |
Q40793043 | Two distinct mechanisms contribute to the constitutive activation of RelB in lymphoid cells. |
Q24311660 | Two genes encode factors with NF-kappa B- and H2TF1-like DNA-binding properties |
Q37485004 | Two transcription factors, NF-kappa B and H2TF1, interact with a single regulatory sequence in the class I major histocompatibility complex promoter |
Q35070246 | Two upstream elements activate transcription of a major histocompatibility complex class I genein vitro |
Q35623604 | URG4/URGCP enhances the angiogenic capacity of human hepatocellular carcinoma cells in vitro via activation of the NF-κB signaling pathway. |
Q35913320 | USP18 negatively regulates NF-κB signaling by targeting TAK1 and NEMO for deubiquitination through distinct mechanisms |
Q36321691 | Ubiquitin protein modification and signal transduction: implications for inflammatory bowel diseases |
Q29616322 | Ubiquitin signalling in the NF-kappaB pathway |
Q26998535 | Ubiquitin-mediated NFκB degradation pathway |
Q36819396 | Ubiquitin-mediated activation of TAK1 and IKK. |
Q41294965 | Ubiquitin-mediated processing of NF-kappa B transcriptional activator precursor p105. Reconstitution of a cell-free system and identification of the ubiquitin-carrier protein, E2, and a novel ubiquitin-protein ligase, E3, involved in conjugation |
Q28274205 | Ubiquitination and degradation of the inhibitors of NF-kappaB |
Q37995681 | Ubiquitination in signaling to and activation of IKK. |
Q39045822 | Understanding NF-kappaB signaling via mathematical modeling |
Q52538370 | Unlocking the NF-κB Conundrum: Embracing Complexity to Achieve Specificity. |
Q33577502 | Up-regulation of Toll-like receptor 4/nuclear factor-kappaB signaling is associated with enhanced adipogenesis and insulin resistance in fetal skeletal muscle of obese sheep at late gestation |
Q43990128 | Up-regulation of cyclooxygenase-2 expression and prostaglandin synthesis in endometrial stromal cells by malignant endometrial epithelial cells. A paracrine effect mediated by prostaglandin E2 and nuclear factor-kappa B. |
Q38820857 | Upregulation of cyclooxygenase-2 is associated with activation of the alternative nuclear factor kappa B signaling pathway in colonic adenocarcinoma |
Q48346819 | Upstream elements involved in vivo in activation of the brain-specific rat aldolase C gene. Role of binding sites for POU and winged helix proteins |
Q35774599 | Vaccinia virus infection of mature dendritic cells results in activation of virus-specific naïve CD8+ T cells: a potential mechanism for direct presentation |
Q40885153 | Variations in genes involved in regulation of the nuclear factor - κB pathway and the risk of acute myeloid leukaemia |
Q36632309 | Varicella-zoster virus open reading frame 4 encodes a transcriptional activator that is functionally distinct from that of herpes simplex virus homology ICP27. |
Q47252915 | Veratramine modulates AP-1-dependent gene transcription by directly binding to programmable DNA. |
Q36230026 | Virus-transformed pre-B cells show ordered activation but not inactivation of immunoglobulin gene rearrangement and transcription |
Q57521562 | Visceral obesity, metabolic syndrome, insulin resistance and cancer |
Q26827754 | When ubiquitin meets NF-κB: a trove for anti-cancer drug development |
Q42456543 | Wild-type p53-mediated induction of rat mdr1b expression by the anticancer drug daunorubicin |
Q37091352 | Wires in the soup: quantitative models of cell signaling |
Q34782247 | ZAS: C2H2 zinc finger proteins involved in growth and development |
Q36826525 | c-Rel, an NF-kappaB family transcription factor, is required for hippocampal long-term synaptic plasticity and memory formation |
Q42943858 | c-rel regulation of IL-2 gene expression may be mediated through activation of AP-1. |
Q48148826 | cactus, a gene involved in dorsoventral pattern formation of Drosophila, is related to the I kappa B gene family of vertebrates |
Q36350859 | cis-acting sequences required for class II gene regulation by interferon gamma and tumor necrosis factor alpha in a murine macrophage cell line |
Q35951032 | kappa B elements strongly activate gene expression in non-lymphoid cells and function synergistically with NF1 elements |
Q33275913 | mTFE3, an X-linked transcriptional activator containing basic helix-loop-helix and zipper domains, utilizes the zipper to stabilize both DNA binding and multimerization |
Q34490836 | miR-200c targets a NF-κB up-regulated TrkB/NTF3 autocrine signaling loop to enhance anoikis sensitivity in triple negative breast cancer |
Q28482491 | miR290-5p/292-5p activate the immunoglobulin kappa locus in B cell development |
Q50067509 | miR‑873 inhibits colorectal cancer cell proliferation by targeting TRAF5 and TAB1. |
Q36550173 | v-rel Induces ectopic expression of an adhesion molecule, DM-GRASP, during B-lymphoma development |
Search more.